Beta-Glucan Market by Category (Soluble, Insoluble), Source (Cereal & Grains, Mushroom, Yeast, Seaweed), Application (Food & Beverage, Dietary Supplement, Personal Care, Cosmetics, Pharmaceutical, Animal Feed), Type and Region - Global Forecast to 2029
The beta-glucan market is on a trajectory to witness substantial growth, with its value expected to soar from USD 542 million in 2024 to an estimated USD 800 million by 2029. This expansion represents a healthy CAGR of 8.1% throughout the projected period. Several key factors are fueling this upward trend, there is a growing consumer preference for natural and clean-label additives in food and beverages. As people become more health-conscious, there's an increasing demand for products that are perceived as natural and wholesome. Beta-glucan, which is a soluble fiber found in various sources such as oats, barley, and mushrooms, fits into this trend perfectly. It not only acts as a natural additive but also offers functional benefits, making it attractive for use in a wide range of food and beverage products.
There is a rising awareness and adoption of high-fiber diets among consumers. High-fiber diets are known to offer a myriad of health benefits, including improved digestive health, better weight management, and reduced risk of chronic diseases like heart disease and diabetes. Beta-glucan, being a soluble fiber, has been shown to help lower cholesterol levels and improve heart health, making it a sought-after ingredient for health-conscious consumers.
“The segment cereals & grains is expected to account for the largest share in 2024.”
Cereals and grains are recognized for their elevated levels of beta-glucan compared to many other food types. Notably, oats and barley are particularly rich in beta-glucan, with oats standing out as one of the most abundant dietary sources. The beta-glucans found in cereals and grains are usually of the mixed-linkage variety, which has demonstrated beneficial health effects, including immune-modulating and cholesterol-reducing properties. Due to their high beta-glucan content, cereals and grains are sought-after sources for obtaining this advantageous compound. Beneo's recent launch of Orafti ?-Fit in July 2023, a barley beta-glucans ingredient, exemplifies the industry's response to increasing awareness of beta-glucans and their health benefits. This innovative product not only offers significant health advantages like improving heart health and blood sugar management but also provides food manufacturers with an appealing ingredient for creating nutritional products. Beneo's introduction of Orafti ?-Fit is part of a broader trend where companies are actively meeting the rising demand for beta-glucans by developing and launching new products. Such initiatives demonstrate the industry's commitment to connecting nutrition and health, addressing consumer needs for functional and health-promoting food options.
“The soluble beta-glucan segment is projected to dominate the market in the category segment during the forecast period.”
Soluble beta-glucan, a form of soluble fiber present in foods like oats, barley, and mushrooms, offers a range of health advantages. These include lowering cholesterol, enhancing immune response, and potentially decreasing the likelihood of certain cancers.
The surging interest in soluble beta-glucan is fueled by an expanding body of research highlighting its health-promoting properties. A 2020 study featured in Nutrients found that incorporating beta-glucan from sources like oats and barley into one's diet can lead to reductions in both total and LDL cholesterol, key indicators of heart disease risk. Furthermore, the study suggested additional cardiovascular benefits associated with beta-glucan, such as diminishing inflammation and boosting endothelial function..
“Changes in dietary choices have positioned North America as a dominating region in the beta-glucan market.”
The North American beta-glucan market is experiencing robust growth, driven by its multifaceted applications across various products and the associated health benefits. Leading market players, including Cargill (US), Millipore Sigma (Germany), and Lesaffre (France), are leveraging technological innovations to expand beta-glucan's use in the food and beverage industry, serving as thickening agents, fat substitutes, dietary fiber, and hypocholesterolemic agents. These advancements are anticipated to fuel market growth in the region.
In the US, consumer trends are shifting towards calorie-conscious choices, leading to a preference for low-calorie and low-fat food options. This change is not only influenced by a general health consciousness but also by the rising prevalence of obesity and cardiovascular diseases. Data from the CDC and the National Health and Nutrition Examination Survey (2021-2022) indicates that the obesity rate among adults in the US has surged to 42.4% between 2020 and 2021.
Furthermore, the escalating number of diabetes cases is reshaping dietary habits, with consumers increasingly seeking natural and low-calorie ingredients to manage their health. Given the significant diabetes prevalence in the US, where 38.4 million people, or 11.6% of the population, have diabetes and an additional 97.6 million adults have prediabetes, there is a growing demand for functional food ingredients like beta-glucan. Beta-glucan's potential benefits in managing blood sugar levels make it a particularly attractive option for diabetes patients and those at risk of developing the condition. As such, the changing dietary habits driven by the diabetes epidemic are expected to further propel the growth of the beta-glucan market in North America.
The break-up of the profile of primary participants in the beta-glucan market:
Other players include VW-Ingredients (Netherlands), Super Beta Glucan(US), GlycaNova AS (Norway), NutriScience Innovations, LLC (US), Algalнf Iceland hf. (Iceland), ABAC R&D (Switzerland), Natural Biologics (New Zealand), BENEO (Germany), L&P Food Ingredient Co., Ltd. (China), Beta Bio Technology sp. z o. o (Poland).
Research Coverage:
This research report categorizes the beta-glucan market by Source (Grains & Cereals, Mushrooms, Yeast, and Seaweed), Category (Soluble and Insoluble), Application (Food & Beverage, Personal Care, Pharmaceutical, Dietary Supplement and Animal Feed), Type ( {1,3} beta-glucan, {1,4} beta-glucan, {1,6} beta-glucan) and region (North America, Europe, Asia Pacific, South America, and Rest of the World). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the beta-glucan market. A detailed analysis of the key industry players has been done to provide insights into their business overview, key strategies, contracts, partnerships & agreements, new product launches, mergers & acquisitions, and recent developments associated with the beta-glucan market. Competitive analysis of upcoming startups in the de-oiled lecithin market ecosystem is covered in this report.
Reasons to buy this report:
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall beta-glucan market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
The report provides insights on the following pointers:
There is a rising awareness and adoption of high-fiber diets among consumers. High-fiber diets are known to offer a myriad of health benefits, including improved digestive health, better weight management, and reduced risk of chronic diseases like heart disease and diabetes. Beta-glucan, being a soluble fiber, has been shown to help lower cholesterol levels and improve heart health, making it a sought-after ingredient for health-conscious consumers.
“The segment cereals & grains is expected to account for the largest share in 2024.”
Cereals and grains are recognized for their elevated levels of beta-glucan compared to many other food types. Notably, oats and barley are particularly rich in beta-glucan, with oats standing out as one of the most abundant dietary sources. The beta-glucans found in cereals and grains are usually of the mixed-linkage variety, which has demonstrated beneficial health effects, including immune-modulating and cholesterol-reducing properties. Due to their high beta-glucan content, cereals and grains are sought-after sources for obtaining this advantageous compound. Beneo's recent launch of Orafti ?-Fit in July 2023, a barley beta-glucans ingredient, exemplifies the industry's response to increasing awareness of beta-glucans and their health benefits. This innovative product not only offers significant health advantages like improving heart health and blood sugar management but also provides food manufacturers with an appealing ingredient for creating nutritional products. Beneo's introduction of Orafti ?-Fit is part of a broader trend where companies are actively meeting the rising demand for beta-glucans by developing and launching new products. Such initiatives demonstrate the industry's commitment to connecting nutrition and health, addressing consumer needs for functional and health-promoting food options.
“The soluble beta-glucan segment is projected to dominate the market in the category segment during the forecast period.”
Soluble beta-glucan, a form of soluble fiber present in foods like oats, barley, and mushrooms, offers a range of health advantages. These include lowering cholesterol, enhancing immune response, and potentially decreasing the likelihood of certain cancers.
The surging interest in soluble beta-glucan is fueled by an expanding body of research highlighting its health-promoting properties. A 2020 study featured in Nutrients found that incorporating beta-glucan from sources like oats and barley into one's diet can lead to reductions in both total and LDL cholesterol, key indicators of heart disease risk. Furthermore, the study suggested additional cardiovascular benefits associated with beta-glucan, such as diminishing inflammation and boosting endothelial function..
“Changes in dietary choices have positioned North America as a dominating region in the beta-glucan market.”
The North American beta-glucan market is experiencing robust growth, driven by its multifaceted applications across various products and the associated health benefits. Leading market players, including Cargill (US), Millipore Sigma (Germany), and Lesaffre (France), are leveraging technological innovations to expand beta-glucan's use in the food and beverage industry, serving as thickening agents, fat substitutes, dietary fiber, and hypocholesterolemic agents. These advancements are anticipated to fuel market growth in the region.
In the US, consumer trends are shifting towards calorie-conscious choices, leading to a preference for low-calorie and low-fat food options. This change is not only influenced by a general health consciousness but also by the rising prevalence of obesity and cardiovascular diseases. Data from the CDC and the National Health and Nutrition Examination Survey (2021-2022) indicates that the obesity rate among adults in the US has surged to 42.4% between 2020 and 2021.
Furthermore, the escalating number of diabetes cases is reshaping dietary habits, with consumers increasingly seeking natural and low-calorie ingredients to manage their health. Given the significant diabetes prevalence in the US, where 38.4 million people, or 11.6% of the population, have diabetes and an additional 97.6 million adults have prediabetes, there is a growing demand for functional food ingredients like beta-glucan. Beta-glucan's potential benefits in managing blood sugar levels make it a particularly attractive option for diabetes patients and those at risk of developing the condition. As such, the changing dietary habits driven by the diabetes epidemic are expected to further propel the growth of the beta-glucan market in North America.
The break-up of the profile of primary participants in the beta-glucan market:
- By Company Type: Tier 1 – 25%, Tier 2 – 45%, and Tier 3 – 30%
- By Designation: CXO’s – 20%, Managers – 50%, Executives- 30%
- By Region: North America – 25%, Europe – 20%, Asia Pacific – 30%, South America – 15% and Rest of the World –10%
Other players include VW-Ingredients (Netherlands), Super Beta Glucan(US), GlycaNova AS (Norway), NutriScience Innovations, LLC (US), Algalнf Iceland hf. (Iceland), ABAC R&D (Switzerland), Natural Biologics (New Zealand), BENEO (Germany), L&P Food Ingredient Co., Ltd. (China), Beta Bio Technology sp. z o. o (Poland).
Research Coverage:
This research report categorizes the beta-glucan market by Source (Grains & Cereals, Mushrooms, Yeast, and Seaweed), Category (Soluble and Insoluble), Application (Food & Beverage, Personal Care, Pharmaceutical, Dietary Supplement and Animal Feed), Type ( {1,3} beta-glucan, {1,4} beta-glucan, {1,6} beta-glucan) and region (North America, Europe, Asia Pacific, South America, and Rest of the World). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the beta-glucan market. A detailed analysis of the key industry players has been done to provide insights into their business overview, key strategies, contracts, partnerships & agreements, new product launches, mergers & acquisitions, and recent developments associated with the beta-glucan market. Competitive analysis of upcoming startups in the de-oiled lecithin market ecosystem is covered in this report.
Reasons to buy this report:
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall beta-glucan market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
The report provides insights on the following pointers:
- Analysis of key drivers (Increase in application of beta glucan in different industries), restraints (Inconsistency in regulatory norms governing beta-glucan), opportunities (Untapped beta-glucan applications), and challenges (Lack of consumer awareness) influencing the growth of the beta-glucan market.
- Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the beta-glucan market.
- Market Development: Comprehensive information about lucrative markets – the report analyses the beta-glucan market across varied regions.
- Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the beta-glucan market.
- Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players such as Tate & Lyle PLC (England), Kerry Group PLC (Ireland), dsm-Firmenich (Switzerland), Merck (Germany), among others in the beta-glucan market strategies. The report also helps stakeholders understand the beta-glucan market and provides them information on key market drivers, restraints, challenges, and opportunities.
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKET SEGMENTATION
1.3.2 INCLUSIONS AND EXCLUSIONS
1.3.3 REGIONS COVERED
1.3.4 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
TABLE 1 USD EXCHANGE RATES, 2019–2023
1.5 UNIT CONSIDERED
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
1.7.1 IMPACT OF RECESSION
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 1 BETA-GLUCAN MARKET: RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 Breakdown of primary profiles
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.1.2.3 Key insights from industry experts
2.2 MARKET SIZE ESTIMATION
2.2.1 TOP-DOWN APPROACH
FIGURE 3 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
2.2.2 SUPPLY-SIDE ANALYSIS
FIGURE 4 BETA-GLUCAN MARKET SIZE CALCULATION: SUPPLY SIDE
2.2.3 BOTTOM-UP APPROACH (DEMAND SIDE)
FIGURE 5 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
2.3 DATA TRIANGULATION AND MARKET BREAKUP
FIGURE 6 DATA TRIANGULATION
2.4 RESEARCH ASSUMPTIONS
2.5 LIMITATIONS AND RISK ASSESSMENT
2.6 RECESSION IMPACT ANALYSIS
2.6.1 MACRO-INDICATORS OF RECESSION
FIGURE 7 RECESSION INDICATORS
FIGURE 8 GLOBAL INFLATION RATE, 2011–2022
FIGURE 9 GLOBAL GDP, 2011–2022 (USD TRILLION)
FIGURE 10 RECESSION INDICATORS AND THEIR IMPACT ON BETA-GLUCAN MARKET
FIGURE 11 GLOBAL BETA-GLUCAN MARKET: EARLIER FORECAST VS. RECESSION FORECAST
3 EXECUTIVE SUMMARY
TABLE 2 BETA-GLUCAN MARKET SHARE SNAPSHOT, 2024 VS. 2029 (USD MILLION)
FIGURE 12 BETA-GLUCAN MARKET, BY SOURCE, 2024 VS. 2029 (USD MILLION)
FIGURE 13 BETA-GLUCAN MARKET, BY CATEGORY, 2024 VS. 2029 (USD MILLION)
FIGURE 14 BETA-GLUCAN MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
FIGURE 15 BETA-GLUCAN MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
FIGURE 16 BETA-GLUCAN MARKET SHARE AND GROWTH RATE, BY REGION, 2024 (BY VALUE)
4 PREMIUM INSIGHTS
4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN BETA-GLUCAN MARKET
FIGURE 17 CONSUMER PREFERENCES FOR HEALTHY AND NUTRITIONAL PROTEIN TO DRIVE BETA-GLUCAN MARKET
4.2 ASIA PACIFIC: BETA-GLUCAN MARKET, BY CATEGORY AND COUNTRY
FIGURE 18 CHINA AND SOLUBLE SEGMENT TO ACCOUNT FOR SIGNIFICANT SHARES IN 2024
4.3 BETA-GLUCAN MARKET, BY TYPE
FIGURE 19 (1,3 BETA-GLUCAN) SEGMENT TO ACCOUNT FOR LARGEST MARKET DURING FORECAST PERIOD
4.4 BETA-GLUCAN MARKET, BY SOURCE
FIGURE 20 CEREALS & GRAINS SEGMENT TO LARGEST MARKET DURING FORECAST PERIOD
4.5 BETA-GLUCAN MARKET, BY CATEGORY
FIGURE 21 SOLUBLE SEGMENT TO ACCOUNT FOR LARGER MARKET DURING FORECAST PERIOD
4.6 BETA-GLUCAN MARKET, BY APPLICATION
FIGURE 22 FOOD & BEVERAGES SEGMENT TO ACCOUNT FOR LARGEST MARKET DURING FORECAST PERIOD
4.7 BETA-GLUCAN MARKET, BY CATEGORY AND REGION
FIGURE 23 SOLUBLE SEGMENT TO LEAD ACROSS ALL REGIONAL MARKETS DURING FORECAST PERIOD
4.8 BETA-GLUCAN MARKET: REGIONAL SNAPSHOT
FIGURE 24 US TO DOMINATE BETA-GLUCAN MARKET IN 2024
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MACROECONOMIC INDICATORS
5.2.1 RISING GLOBAL DOMESTIC PRODUCT AND POPULATION GROWTH TO DRIVE APPETITE FOR BETA-GLUCAN
FIGURE 25 GLOBAL POPULATION GROWTH, 1950–2050 (BILLION)
FIGURE 26 GDP GROWTH, 2016–2022 (TRILLION)
5.2.2 RISING HEALTH CONCERNS AND GROWTH IN DISEASES
FIGURE 27 PERCENTAGE POPULATION OF CANCER PATIENTS, BY REGION, 2022
5.2.3 INCREASE IN CONSUMPTION OF DIETARY FIBERS
5.3 MARKET DYNAMICS
FIGURE 28 BETA-GLUCAN MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.3.1 DRIVERS
5.3.1.1 Growth in health consciousness and increasing health expenditure
FIGURE 29 GLOBAL OECD HEALTH SPENDING AS SHARE OF GLOBAL DOMESTIC PRODUCT, 2017–2021
5.3.1.2 Increasing research and application of beta-glucan in fast-moving industries
5.3.2 RESTRAINTS
5.3.2.1 Inconsistency in regulatory norms governing beta-glucan
5.3.2.2 Price volatility of raw materials
5.3.3 OPPORTUNITIES
5.3.3.1 Growing demand for natural and plant-based ingredients
5.3.3.2 Demand for personalized nutrition and tailored beta-glucan products
5.3.3.3 Untapped beta-glucan applications
5.3.4 CHALLENGES
5.3.4.1 Lack of consumer awareness regarding benefits of beta-glucan
5.3.4.2 High research and development costs
6 INDUSTRY TRENDS
6.1 INTRODUCTION
6.2 SUPPLY CHAIN ANALYSIS
FIGURE 30 BETA-GLUCAN MARKET: SUPPLY CHAIN ANALYSIS
6.3 VALUE CHAIN ANALYSIS
FIGURE 31 BETA-GLUCAN MARKET: VALUE CHAIN ANALYSIS
6.3.1 RESEARCH & DEVELOPMENT
6.3.2 RAW MATERIAL SOURCING
6.3.3 PRODUCTION
6.3.4 DISTRIBUTION
6.3.5 END USERS
6.4 TRADE ANALYSIS
6.4.1 IMPORT SCENARIO OF YEAST
FIGURE 32 HS CODE 2102: IMPORT VALUE OF YEAST, BY KEY COUNTRY, 2019–2023
TABLE 3 HS CODE 2102: IMPORT SCENARIO OF YEAST, BY COUNTRY, 2022 (USD)
6.4.2 EXPORT SCENARIO OF YEAST
FIGURE 33 HS CODE 2102: EXPORT VALUE OF YEAST, BY KEY COUNTRY, 2019–2023
TABLE 4 HS CODE 2102: EXPORT SCENARIO OF YEAST, BY COUNTRY, 2022 (USD)
6.4.3 IMPORT SCENARIO OF MUSHROOMS
FIGURE 34 HS CODE 2003: IMPORT VALUE OF MUSHROOMS, BY KEY COUNTRY, 2019–2023
TABLE 5 HS CODE 2003: IMPORT SCENARIO OF MUSHROOMS, BY COUNTRY, 2022 (USD)
6.4.4 EXPORT SCENARIO OF MUSHROOMS
FIGURE 35 HS CODE 2003: EXPORT VALUE OF MUSHROOMS, BY KEY COUNTRY, 2019–2023
TABLE 6 HS CODE 2003: EXPORT SCENARIO OF MUSHROOMS, BY COUNTRY, 2022 (USD)
6.4.5 IMPORT SCENARIO OF OATS
FIGURE 36 HS CODE 1004: IMPORT VALUE OF OATS, BY KEY COUNTRY, 2019–2023
TABLE 7 HS CODE 1004: IMPORT SCENARIO OF OATS, BY COUNTRY, 2022 (USD)
6.4.6 EXPORT SCENARIO OF OATS
FIGURE 37 HS CODE 1004: EXPORT VALUE OF OATS, BY KEY COUNTRY, 2019–2023
TABLE 8 HS CODE 1004: EXPORT SCENARIO OF OATS, BY COUNTRY, 2022 (USD)
6.4.7 IMPORT SCENARIO OF BARLEY
FIGURE 38 HS CODE 1003: IMPORT VALUE OF BARLEY, BY KEY COUNTRY, 2019–2023
TABLE 9 HS CODE 1003: IMPORT SCENARIO OF BARLEY, BY COUNTRY, 2022 (USD)
6.4.8 EXPORT SCENARIO OF BARLEY
FIGURE 39 HS CODE 1003: EXPORT VALUE OF BARLEY, BY KEY COUNTRY, 2019–2023
TABLE 10 HS CODE 1003: EXPORT SCENARIO OF BARLEY, BY COUNTRY, 2022 (USD)
6.5 TECHNOLOGY ANALYSIS
6.5.1 KEY TECHNOLOGIES
6.5.1.1 Encapsulation
6.5.2 COMPLEMENTARY TECHNOLOGIES
6.5.2.1 High-purity yeast beta-glucan technology
6.5.3 ADJACENT TECHNOLOGIES
6.5.3.1 New avenues for yeast culture and extraction
6.6 PRICING ANALYSIS
6.6.1 AVERAGE SELLING PRICE TREND, BY REGION
TABLE 11 BETA-GLUCAN MARKET: AVERAGE SELLING PRICE TREND, BY REGION, 2023–2029 (USD/TONS)
6.6.2 AVERAGE SELLING PRICE TREND, BY SOURCE
TABLE 12 BETA-GLUCAN MARKET: AVERAGE SELLING PRICE TREND, BY SOURCE, 2023–2029 (USD/TONS)
FIGURE 40 AVERAGE SELLING PRICE TREND, BY SOURCE (USD/TONS)
6.7 ECOSYSTEM/MARKET MAP
6.7.1 DEMAND SIDE
6.7.2 SUPPLY SIDE
FIGURE 41 KEY PLAYERS IN BETA-GLUCAN MARKET ECOSYSTEM
TABLE 13 BETA-GLUCAN MARKET: ECOSYSTEM
6.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 42 REVENUE SHIFT FOR BETA-GLUCAN MARKET VENDORS
6.9 PATENT ANALYSIS
TABLE 14 LIST OF MAJOR PATENTS PERTAINING TO BETA-GLUCAN MARKET, 2014–2024
FIGURE 43 NUMBER OF PATENTS GRANTED FOR BETA-GLUCAN, 2014–2023
FIGURE 44 REGIONAL ANALYSIS OF PATENTS GRANTED FOR BETA-GLUCAN
6.10 KEY CONFERENCES AND EVENTS
TABLE 15 BETA-GLUCAN MARKET: LIST OF KEY CONFERENCES AND EVENTS, 2024
6.11 REGULATORY LANDSCAPE
6.11.1 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
6.11.1.1 North America
TABLE 16 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
6.11.1.2 Europe
TABLE 17 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
6.11.1.3 Asia Pacific
TABLE 18 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
6.11.1.4 RoW
TABLE 19 ROW: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
6.11.2 REGULATORY FRAMEWORK
6.11.2.1 Introduction
6.11.2.2 North America
6.11.2.2.1 US Food and Drug Administration (21CFR101.14)
6.11.2.2.2 US Food and Drug Administration (21CFR101.81)
6.11.2.3 European Food Safety Authority
6.11.2.3.1 European Union
6.12 PORTER’S FIVE FORCES’ ANALYSIS
TABLE 20 PORTER’S FIVE FORCES’ IMPACT ON BETA-GLUCAN MARKET
6.12.1 THREAT OF NEW ENTRANTS
6.12.2 THREAT OF SUBSTITUTES
6.12.3 BARGAINING POWER OF SUPPLIERS
6.12.4 BARGAINING POWER OF BUYERS
6.12.5 INTENSITY OF COMPETITIVE RIVALRY
6.13 KEY STAKEHOLDERS AND BUYING CRITERIA
6.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 45 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP APPLICATIONS
TABLE 21 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP APPLICATIONS
6.13.2 BUYING CRITERIA
TABLE 22 KEY BUYING CRITERIA FOR TOP APPLICATIONS
FIGURE 46 KEY BUYING CRITERIA FOR TOP APPLICATIONS
6.14 CASE STUDY ANALYSIS
6.14.1 CARGILL INVESTED USD 35 MILLION TO PRODUCE SOLUBLE FIBERS THAT MEET CONSUMER DEMAND FOR HEALTHY PRODUCTS
6.14.2 TATE & LYLE ENTERED INTO PARTNERSHIP WITH SOLEVO TO DISTRIBUTE WIDE RANGE OF PRODUCTS AND TAP UNTAPPED OPPORTUNITIES
6.15 BETA-GLUCAN PURITY ANALYSIS
6.15.1 ACIDIC EXTRACTION
6.15.2 ALKALINE EXTRACTION
6.15.3 WATER EXTRACTION
6.15.4 ENZYMATIC EXTRACTION
7 BETA-GLUCAN MARKET, BY EXTRACTION METHOD
7.1 INTRODUCTION
TABLE 23 BETA-GLUCAN YIELDS AND PRODUCTION TECHNOLOGIES FROM VARIOUS SOURCES
7.2 BETA-GLUCAN FROM CEREALS
7.3 BETA-GLUCAN FROM YEAST
8 BETA-GLUCAN MARKET, BY APPLICATION
8.1 INTRODUCTION
TABLE 24 APPLICATION OVERVIEW
FIGURE 47 BETA-GLUCAN MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
TABLE 25 BETA-GLUCAN MARKET: BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 26 BETA-GLUCAN MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
8.2 FOOD & BEVERAGES
8.2.1 INCREASING AWARENESS OF HEALTH BENEFITS IN PREVENTING AND MANAGING CHRONIC DISEASES TO DRIVE DEMAND FOR BETA-GLUCAN
TABLE 27 FOOD & BEVERAGES: BETA-GLUCAN MARKET, BY REGION, 2019–2023 (USD MILLION)
TABLE 28 FOOD & BEVERAGES: BETA-GLUCAN MARKET, BY REGION, 2024–2029 (USD MILLION)
8.3 PERSONAL CARE
8.3.1 GROWING CONSUMER DEMAND FOR NATURAL AND HEALTHY PRODUCTS AND AWARENESS REGARDING SKIN HEALTH TO PROPEL MARKET
TABLE 29 PERSONAL CARE: BETA-GLUCAN MARKET, BY REGION, 2019–2023 (USD MILLION)
TABLE 30 PERSONAL CARE: BETA-GLUCAN MARKET, BY REGION, 2024–2029 (USD MILLION)
8.3.1.1 By form
8.3.1.1.1 Creams
8.3.1.1.2 Lotions
8.3.1.1.3 Other personal care forms
TABLE 31 PERSONAL CARE: BETA-GLUCAN MARKET, BY FORM, 2019–2023 (USD MILLION)
TABLE 32 PERSONAL CARE: BETA-GLUCAN MARKET, BY FORM, 2024–2029 (USD MILLION)
8.3.1.2 By functionality
8.3.1.2.1 Spot reduction
8.3.1.2.2 Skin treatment/Wound healing
8.3.1.2.3 Skin moisturization & hydration
8.3.1.2.4 Anti-irritation/Anti-inflammatory
8.3.1.2.5 Collagen stimulation & anti-aging
8.3.1.2.6 Other personal care functionalities
TABLE 33 PERSONAL CARE: BETA-GLUCAN MARKET, BY FUNCTIONALITY, 2019–2023 (USD MILLION)
TABLE 34 PERSONAL CARE: BETA-GLUCAN MARKET, BY FUNCTIONALITY, 2024–2029 (USD MILLION)
8.4 COSMETICS
8.4.1 BETA-GLUCAN TO IMPROVE SPREADABILITY OF FORMULATIONS AND ENHANCE THEIR ADHERENCE TO SKIN
TABLE 35 COSMETICS: BETA-GLUCAN MARKET, BY REGION, 2019–2023 (USD MILLION)
TABLE 36 COSMETICS: BETA-GLUCAN MARKET, BY REGION, 2024–2029 (USD MILLION)
8.4.1.1 By form
8.4.1.1.1 Creams
8.4.1.1.2 Lotions
8.4.1.1.3 Other cosmetics forms
TABLE 37 COSMETICS: BETA-GLUCAN MARKET, BY FORM, 2019–2023 (USD MILLION)
TABLE 38 COSMETICS: BETA-GLUCAN MARKET, BY FORM, 2024–2029 (USD MILLION)
8.4.1.2 By functionality
8.4.1.2.1 UV protection
8.4.1.2.2 Barrier enhancement
8.4.1.2.3 Skin moisturization & hydration
8.4.1.2.4 Collagen stimulation & anti-aging
8.4.1.2.5 Other cosmetics functionalities
TABLE 39 COSMETICS: BETA-GLUCAN MARKET, BY FUNCTIONALITY, 2019–2023 (USD MILLION)
TABLE 40 COSMETICS: BETA-GLUCAN MARKET, BY FUNCTIONALITY, 2024–2029 (USD MILLION)
8.5 PHARMACEUTICALS
8.5.1 GOVERNMENT INVESTMENT IN BENEFITS OF BETA-GLUCAN IN PHARMACEUTICAL APPLICATIONS TO SPUR MARKET
TABLE 41 PHARMACEUTICALS: BETA-GLUCAN MARKET, BY REGION, 2019–2023 (USD MILLION)
TABLE 42 PHARMACEUTICALS: BETA-GLUCAN MARKET, BY REGION, 2024–2029 (USD MILLION)
8.6 DIETARY SUPPLEMENTS
8.6.1 NEED FOR IMMUNE SYSTEM SUPPORT, CHOLESTEROL REDUCTION, AND IMPROVED GUT HEALTH TO FUEL DEMAND FOR BETA-GLUCAN
TABLE 43 DIETARY SUPPLEMENTS: BETA-GLUCAN MARKET, BY REGION, 2019–2023 (USD MILLION)
TABLE 44 DIETARY SUPPLEMENTS: BETA-GLUCAN MARKET, BY REGION, 2024–2029 (USD MILLION)
8.7 ANIMAL FEED
8.7.1 BETA-GLUCAN TO IMPROVE GROWTH AND FEED EFFICIENCY IN LIVESTOCK AND HELP THEM RESIST INFECTIONS AND DISEASES
TABLE 45 ANIMAL FEED: BETA-GLUCAN MARKET, BY REGION, 2019–2023 (USD MILLION)
TABLE 46 ANIMAL FEED: BETA-GLUCAN MARKET, BY REGION, 2024–2029 (USD MILLION)
TABLE 47 ANIMAL FEED: BETA-GLUCAN MARKET, BY SUB-APPLICATION, 2019–2023 (USD MILLION)
TABLE 48 ANIMAL FEED: BETA-GLUCAN MARKET, BY SUB-APPLICATION, 2024–2029 (USD MILLION)
8.7.1.1 Pets
8.7.1.2 Livestock
9 BETA-GLUCAN MARKET, BY BRAND
9.1 INTRODUCTION
9.2 EPICOR
9.3 BETAVIA
9.4 M-GARD
9.5 AVENACARE
9.6 AB BIOTEK HUMAN NUTRITION AND HEALTH
9.7 YESTIMUN
9.8 BENICAROS
9.9 IMMUDYNE NUTRITIONAL PUREMUNE
9.10 WELLMUNE
9.11 OTHER BRANDS
9.11.1 OATWELL
9.11.2 PROMOAT
9.11.3 SANACEL
9.11.4 AVENACARE
9.11.5 NUTRIM
10 BETA-GLUCAN MARKET, BY CATEGORY
10.1 INTRODUCTION
FIGURE 48 BETA-GLUCAN MARKET, BY CATEGORY, 2024 VS. 2029 (USD MILLION)
TABLE 49 BETA-GLUCAN MARKET, BY CATEGORY, 2019–2023 (USD MILLION)
TABLE 50 BETA-GLUCAN MARKET, BY CATEGORY, 2024–2029 (USD MILLION)
10.2 SOLUBLE BETA-GLUCAN
10.2.1 SOLUBLE BETA-GLUCAN TO REDUCE CHOLESTEROL LEVELS AND IMPROVE IMMUNE FUNCTION
TABLE 51 SOLUBLE: BETA-GLUCAN MARKET, BY REGION, 2019–2023 (USD MILLION)
TABLE 52 SOLUBLE: BETA-GLUCAN MARKET, BY REGION, 2024–2029 (USD MILLION)
10.3 INSOLUBLE BETA-GLUCAN
10.3.1 INSOLUBLE BETA-GLUCAN TO MAINTAIN HEALTHY DIGESTIVE SYSTEM BY FACILITATING SMOOTH MOVEMENT OF FOOD THROUGH DIGESTIVE TRACT
TABLE 53 INSOLUBLE: BETA-GLUCAN MARKET, BY REGION, 2019–2023 (USD MILLION)
TABLE 54 INSOLUBLE: BETA-GLUCAN MARKET, BY REGION, 2024–2029 (USD MILLION)
11 BETA-GLUCAN MARKET, BY SOURCE
11.1 INTRODUCTION
FIGURE 49 BETA-GLUCAN MARKET, BY SOURCE, 2024 VS. 2029 (USD MILLION)
TABLE 55 BETA-GLUCAN MARKET, BY SOURCE, 2019–2023 (USD MILLION)
TABLE 56 BETA-GLUCAN MARKET, BY SOURCE, 2024–2029 (USD MILLION)
TABLE 57 BETA-GLUCAN MARKET, BY SOURCE, 2019–2023 (TONS)
TABLE 58 BETA-GLUCAN MARKET, BY SOURCE, 2024–2029 (TONS)
11.2 CEREALS & GRAINS
11.2.1 NEED FOR REDUCING CHOLESTEROL LEVELS, IMPROVING HEART HEALTH, AND BOOSTING IMMUNE SYSTEM TO DRIVE MARKET
TABLE 59 CEREALS & GRAINS: BETA-GLUCAN MARKET, BY REGION, 2019–2023 (USD MILLION)
TABLE 60 CEREALS & GRAINS: BETA-GLUCAN MARKET, BY REGION, 2024–2029 (USD MILLION)
TABLE 61 CEREALS & GRAINS: BETA-GLUCAN MARKET, BY REGION, 2019–2023 (TONS)
TABLE 62 CEREALS & GRAINS: BETA-GLUCAN MARKET, BY REGION, 2024–2029 (TONS)
11.3 MUSHROOMS
11.3.1 GLUCAN FROM MUSHROOMS TO OFFER IMMUNE HEALTH BENEFITS AND IMPROVE SKIN HEALTH AND ANTI-INFLAMMATORY EFFECTS
TABLE 63 MUSHROOMS: BETA-GLUCAN MARKET, BY REGION, 2019–2023 (USD MILLION)
TABLE 64 MUSHROOMS: BETA-GLUCAN MARKET, BY REGION, 2024–2029 (USD MILLION)
TABLE 65 MUSHROOMS: BETA-GLUCAN MARKET, BY REGION, 2019–2023 (TONS)
TABLE 66 MUSHROOMS: BETA-GLUCAN MARKET, BY REGION, 2024–2029 (TONS)
11.4 YEAST
11.4.1 RISING PREVALENCE OF CHRONIC DISEASES, GROWING AWARENESS ABOUT HEALTH BENEFITS OF BETA-GLUCAN, AND SUPPORT OF GOVERNMENTS FOR RESEARCH AND DEVELOPMENT TO FOSTER MARKET
TABLE 67 YEAST: BETA-GLUCAN MARKET, BY REGION, 2019–2023 (USD MILLION)
TABLE 68 YEAST: BETA-GLUCAN MARKET, BY REGION, 2024–2029 (USD MILLION)
TABLE 69 YEAST: BETA-GLUCAN MARKET, BY REGION, 2019–2023 (TONS)
TABLE 70 YEAST: BETA-GLUCAN MARKET, BY REGION, 2024–2029 (TONS)
11.5 SEAWEED
11.5.1 SEAWEED-BASED BETA-GLUCAN TO BE USED IN COSMETIC AND PERSONAL CARE PRODUCTS FOR ITS MOISTURIZING, ANTI-INFLAMMATORY, AND ANTIOXIDANT PROPERTIES
TABLE 71 SEAWEED: BETA-GLUCAN MARKET, BY REGION, 2019–2023 (USD MILLION)
TABLE 72 SEAWEED: BETA-GLUCAN MARKET, BY REGION, 2024–2029 (USD MILLION)
TABLE 73 SEAWEED: BETA-GLUCAN MARKET, 2019–2023 (TONS)
TABLE 74 SEAWEED: BETA-GLUCAN MARKET, 2024–2029 (TONS)
12 BETA-GLUCAN MARKET, BY TYPE
12.1 INTRODUCTION
FIGURE 50 BETA-GLUCAN MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
TABLE 75 BETA-GLUCAN MARKET, BY TYPE, 2019–2023 (USD MILLION)
TABLE 76 BETA-GLUCAN MARKET, BY TYPE, 2024–2029 (USD MILLION)
12.2 1,3 BETA-GLUCAN
12.2.1 1,3 BETA-GLUCAN TO ENHANCE IMMUNE FUNCTION BY ACTIVATING VARIOUS IMMUNE CELLS AND IMPROVE SKIN HEALTH
TABLE 77 1,3 BETA-GLUCAN: BETA-GLUCAN MARKET, BY REGION, 2019–2023 (USD MILLION)
TABLE 78 1,3 BETA-GLUCAN: BETA-GLUCAN MARKET, BY REGION, 2024–2029 (USD MILLION)
12.3 1,4 BETA-GLUCAN
12.3.1 OAT AND BARLEY-DERIVED 1,4 BETA-GLUCAN TO LOWER CHOLESTEROL AND ENHANCE CARDIOVASCULAR HEALTH
TABLE 79 1,4 BETA-GLUCAN: BETA-GLUCAN MARKET, BY REGION, 2019–2023 (USD MILLION)
TABLE 80 1,4 BETA-GLUCAN: BETA-GLUCAN MARKET, BY REGION, 2024–2029 (USD MILLION)
12.4 1,6 BETA-GLUCAN
12.4.1 DEMAND FOR 1,6 BETA-GLUCAN TO RISE DUE TO ITS IMMUNE-BOOSTING AND SKIN HEALTH BENEFITS
TABLE 81 1,6 BETA-GLUCAN: BETA-GLUCAN MARKET, BY REGION, 2019–2023 (USD MILLION)
TABLE 82 1,6 BETA-GLUCAN: BETA-GLUCAN MARKET, BY REGION, 2024–2029 (USD MILLION)
13 BETA-GLUCAN MARKET, BY REGION
13.1 INTRODUCTION
FIGURE 51 ASIA PACIFIC COUNTRIES TO WITNESS SIGNIFICANT GROWTH IN BETA-GLUCAN MARKET, 2024–2029
TABLE 83 BETA-GLUCAN MARKET, BY REGION, 2019–2023 (USD MILLION)
TABLE 84 BETA-GLUCAN MARKET, BY REGION, 2024–2029 (USD MILLION)
TABLE 85 BETA-GLUCAN MARKET, BY REGION, 2019–2023 (TONS)
TABLE 86 BETA-GLUCAN MARKET, BY REGION, 2024–2029 (TONS)
13.2 NORTH AMERICA
FIGURE 52 NORTH AMERICA: BETA-GLUCAN MARKET SNAPSHOT
13.2.1 NORTH AMERICA: RECESSION IMPACT ANALYSIS
FIGURE 53 NORTH AMERICA: COUNTRY-LEVEL DATA OF INFLATION, 2017–2022
FIGURE 54 NORTH AMERICAN BETA-GLUCAN MARKET: RECESSION IMPACT ANALYSIS
TABLE 87 NORTH AMERICA: BETA-GLUCAN MARKET, BY COUNTRY, 2019–2023 (USD MILLION)
TABLE 88 NORTH AMERICA: BETA-GLUCAN MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
TABLE 89 NORTH AMERICA: BETA-GLUCAN MARKET, BY SOURCE, 2019–2023 (USD MILLION)
TABLE 90 NORTH AMERICA: BETA-GLUCAN MARKET, BY SOURCE, 2024–2029 (USD MILLION)
TABLE 91 NORTH AMERICA: BETA-GLUCAN MARKET, BY SOURCE, 2019–2023 (TONS)
TABLE 92 NORTH AMERICA: BETA-GLUCAN MARKET, BY SOURCE, 2024–2029 (TONS)
TABLE 93 NORTH AMERICA: BETA-GLUCAN MARKET, BY CATEGORY, 2019–2023 (USD MILLION)
TABLE 94 NORTH AMERICA: BETA-GLUCAN MARKET, BY CATEGORY, 2024–2029 (USD MILLION)
TABLE 95 NORTH AMERICA: BETA-GLUCAN MARKET, BY TYPE, 2019–2023 (USD MILLION)
TABLE 96 NORTH AMERICA: BETA-GLUCAN MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 97 NORTH AMERICA: BETA-GLUCAN MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 98 NORTH AMERICA: BETA-GLUCAN MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 99 NORTH AMERICA: BETA-GLUCAN PERSONAL CARE MARKET, BY FORM, 2019–2023 (USD MILLION)
TABLE 100 NORTH AMERICA: BETA-GLUCAN PERSONAL CARE MARKET, BY FORM, 2024–2029 (USD MILLION)
TABLE 101 NORTH AMERICA: BETA-GLUCAN PERSONAL CARE MARKET, BY FUNCTIONALITY, 2019–2023 (USD MILLION)
TABLE 102 NORTH AMERICA: BETA-GLUCAN PERSONAL CARE MARKET, BY FUNCTIONALITY, 2024–2029 (USD MILLION)
TABLE 103 NORTH AMERICA: BETA-GLUCAN COSMETICS MARKET, BY FORM, 2019–2023 (USD MILLION)
TABLE 104 NORTH AMERICA: BETA-GLUCAN COSMETICS MARKET, BY FORM, 2024–2029 (USD MILLION)
TABLE 105 NORTH AMERICA: BETA-GLUCAN COSMETICS MARKET, BY FUNCTIONALITY, 2019–2023 (USD MILLION)
TABLE 106 NORTH AMERICA: BETA-GLUCAN COSMETICS MARKET, BY FUNCTIONALITY, 2024–2029 (USD MILLION)
TABLE 107 NORTH AMERICA: BETA-GLUCAN ANIMAL FEED MARKET, BY SUB-APPLICATION, 2019–2023 (USD MILLION)
TABLE 108 NORTH AMERICA: BETA-GLUCAN ANIMAL FEED MARKET, BY SUB-APPLICATION, 2024–2029 (USD MILLION)
13.2.2 US
13.2.2.1 Increasing number of product launches by food manufacturers to fuel demand for beta-glucan
TABLE 109 US: BETA-GLUCAN MARKET, BY CATEGORY, 2019–2023 (USD MILLION)
TABLE 110 US: BETA-GLUCAN MARKET, BY CATEGORY, 2024–2029 (USD MILLION)
TABLE 111 US: BETA-GLUCAN MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 112 US: BETA-GLUCAN MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
13.2.3 CANADA
13.2.3.1 Government approvals and rising efforts from market players to accelerate market growth
TABLE 113 CANADA: BETA-GLUCAN MARKET, BY CATEGORY, 2019–2023 (USD MILLION)
TABLE 114 CANADA: BETA-GLUCAN MARKET, BY CATEGORY, 2024–2029 (USD MILLION)
TABLE 115 CANADA: BETA-GLUCAN MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 116 CANADA: BETA-GLUCAN MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
13.2.4 MEXICO
13.2.4.1 Rise in chronic lifestyle diseases, demand for health-benefiting products, and government initiatives to promote healthy lifestyles to drive market
TABLE 117 MEXICO: BETA-GLUCAN MARKET, BY CATEGORY, 2019–2023 (USD MILLION)
TABLE 118 MEXICO: BETA-GLUCAN MARKET, BY CATEGORY, 2024–2029 (USD MILLION)
TABLE 119 MEXICO: BETA-GLUCAN MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 120 MEXICO: BETA-GLUCAN MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
13.3 EUROPE
13.3.1 EUROPE: RECESSION IMPACT ANALYSIS
FIGURE 55 EUROPE: COUNTRY-LEVEL DATA FOR INFLATION, 2017–2022
FIGURE 56 EUROPEAN BETA-GLUCAN MARKET: RECESSION IMPACT ANALYSIS
TABLE 121 EUROPE: BETA-GLUCAN MARKET, BY COUNTRY, 2019–2023 (USD MILLION)
TABLE 122 EUROPE: BETA-GLUCAN MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
TABLE 123 EUROPE: BETA-GLUCAN MARKET, BY SOURCE, 2019–2023 (USD MILLION)
TABLE 124 EUROPE: BETA-GLUCAN MARKET, BY SOURCE, 2024–2029 (USD MILLION)
TABLE 125 EUROPE: BETA-GLUCAN MARKET, BY SOURCE, 2019–2023 (TONS)
TABLE 126 EUROPE: BETA-GLUCAN MARKET, BY SOURCE, 2024–2029 (TONS)
TABLE 127 EUROPE: BETA-GLUCAN MARKET, BY CATEGORY, 2019–2023 (USD MILLION)
TABLE 128 EUROPE: BETA-GLUCAN MARKET, BY CATEGORY, 2024–2029 (USD MILLION)
TABLE 129 EUROPE: BETA-GLUCAN MARKET, BY TYPE, 2019–2023 (USD MILLION)
TABLE 130 EUROPE: BETA-GLUCAN MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 131 EUROPE: BETA-GLUCAN MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 132 EUROPE: BETA-GLUCAN MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 133 EUROPE: BETA-GLUCAN PERSONAL CARE MARKET, BY FORM, 2019–2023 (USD MILLION)
TABLE 134 EUROPE: BETA-GLUCAN PERSONAL CARE MARKET, BY FORM, 2024–2029 (USD MILLION)
TABLE 135 EUROPE: BETA-GLUCAN PERSONAL CARE MARKET, BY FUNCTIONALITY, 2019–2023 (USD MILLION)
TABLE 136 EUROPE: BETA-GLUCAN PERSONAL CARE MARKET, BY FUNCTIONALITY, 2024–2029 (USD MILLION)
TABLE 137 EUROPE: BETA-GLUCAN COSMETICS MARKET, BY FORM, 2019–2023 (USD MILLION)
TABLE 138 EUROPE: BETA-GLUCAN COSMETICS MARKET, BY FORM, 2024–2029 (USD MILLION)
TABLE 139 EUROPE: BETA-GLUCAN COSMETICS MARKET, BY FUNCTIONALITY, 2019–2023 (USD MILLION)
TABLE 140 EUROPE: BETA-GLUCAN COSMETICS MARKET, BY FUNCTIONALITY, 2024–2029 (USD MILLION)
TABLE 141 EUROPE: BETA-GLUCAN ANIMAL FEED MARKET, BY SUB-APPLICATION, 2019–2023 (USD MILLION)
TABLE 142 EUROPE: BETA-GLUCAN ANIMAL FEED MARKET, BY SUB-APPLICATION, 2024–2029 (USD MILLION)
13.3.2 GERMANY
13.3.2.1 Inclination toward natural and organic foods and rising prevalence of health-related problems to propel market
TABLE 143 GERMANY: BETA-GLUCAN MARKET, BY CATEGORY, 2019–2023 (USD MILLION)
TABLE 144 GERMANY: BETA-GLUCAN MARKET, BY CATEGORY, 2024–2029 (USD MILLION)
TABLE 145 GERMANY: BETA-GLUCAN MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 146 GERMANY: BETA-GLUCAN MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
13.3.3 FRANCE
13.3.3.1 Rising incidence of lifestyle diseases, growing demand for functional foods, and favorable government policies to drive market
TABLE 147 FRANCE: BETA-GLUCAN MARKET, BY CATEGORY, 2019–2023 (USD MILLION)
TABLE 148 FRANCE: BETA-GLUCAN MARKET, BY CATEGORY, 2024–2029 (USD MILLION)
TABLE 149 FRANCE: BETA-GLUCAN MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 150 FRANCE: BETA-GLUCAN MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
13.3.4 UK
13.3.4.1 Rising demand for healthier and more sustainable products and government’s focus on awareness programs to promote healthy diet to drive market
TABLE 151 UK: BETA-GLUCAN MARKET, BY CATEGORY, 2019–2023 (USD MILLION)
TABLE 152 UK: BETA-GLUCAN MARKET, BY CATEGORY, 2024–2029 (USD MILLION)
TABLE 153 UK: BETA-GLUCAN MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 154 UK: BETA-GLUCAN MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
13.3.5 ITALY
13.3.5.1 Rising demand for health-enriching ingredients to prevent risk of chronic diseases to foster market growth
TABLE 155 ITALY: BETA-GLUCAN MARKET, BY CATEGORY, 2019–2023 (USD MILLION)
TABLE 156 ITALY: BETA-GLUCAN MARKET, BY CATEGORY, 2024–2029 (USD MILLION)
TABLE 157 ITALY: BETA-GLUCAN MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 158 ITALY: BETA-GLUCAN MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
13.3.6 SPAIN
13.3.6.1 Rising export opportunities and need to optimize animal health to boost demand for beta-glucan
TABLE 159 SPAIN: BETA-GLUCAN MARKET, BY CATEGORY, 2019–2023 (USD MILLION)
TABLE 160 SPAIN: BETA-GLUCAN MARKET, BY CATEGORY, 2024–2029 (USD MILLION)
TABLE 161 SPAIN: BETA-GLUCAN MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 162 SPAIN: BETA-GLUCAN MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
13.3.7 REST OF EUROPE
TABLE 163 REST OF EUROPE: BETA-GLUCAN MARKET, BY CATEGORY, 2019–2023 (USD MILLION)
TABLE 164 REST OF EUROPE: BETA-GLUCAN MARKET, BY CATEGORY, 2024–2029 (USD MILLION)
TABLE 165 REST OF EUROPE: BETA-GLUCAN MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 166 REST OF EUROPE: BETA-GLUCAN MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
13.4 ASIA PACIFIC
FIGURE 57 ASIA PACIFIC: BETA-GLUCAN MARKET SNAPSHOT
13.4.1 ASIA PACIFIC: RECESSION IMPACT ANALYSIS
FIGURE 58 ASIA PACIFIC: KEY COUNTRY-WISE INFLATION RATES, 2017–2022
FIGURE 59 ASIA PACIFIC: RECESSION IMPACT ANALYSIS, 2023
TABLE 167 ASIA PACIFIC: BETA-GLUCAN MARKET, BY COUNTRY, 2019–2023 (USD MILLION)
TABLE 168 ASIA PACIFIC: BETA-GLUCAN MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
TABLE 169 ASIA PACIFIC: BETA-GLUCAN MARKET, BY SOURCE, 2019–2023 (USD MILLION)
TABLE 170 ASIA PACIFIC: BETA-GLUCAN MARKET, BY SOURCE, 2024–2029 (USD MILLION)
TABLE 171 ASIA PACIFIC: BETA-GLUCAN MARKET, BY SOURCE, 2019–2023 (TONS)
TABLE 172 ASIA PACIFIC: BETA-GLUCAN MARKET, BY SOURCE, 2024–2029 (TONS)
TABLE 173 ASIA PACIFIC: BETA-GLUCAN MARKET, BY CATEGORY, 2019–2023 (USD MILLION)
TABLE 174 ASIA PACIFIC: BETA-GLUCAN MARKET, BY CATEGORY, 2024–2029 (USD MILLION)
TABLE 175 ASIA PACIFIC: BETA-GLUCAN MARKET, BY TYPE, 2019–2023 (USD MILLION)
TABLE 176 ASIA PACIFIC: BETA-GLUCAN MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 177 ASIA PACIFIC: BETA-GLUCAN MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 178 ASIA PACIFIC: BETA-GLUCAN MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 179 ASIA PACIFIC: BETA-GLUCAN PERSONAL CARE MARKET, BY FORM, 2019–2023 (USD MILLION)
TABLE 180 ASIA PACIFIC: BETA-GLUCAN PERSONAL CARE MARKET, BY FORM, 2024–2029 (USD MILLION)
TABLE 181 ASIA PACIFIC: BETA-GLUCAN PERSONAL CARE MARKET, BY FUNCTIONALITY, 2019–2023 (USD MILLION)
TABLE 182 ASIA PACIFIC: BETA-GLUCAN PERSONAL CARE MARKET, BY FUNCTIONALITY, 2024–2029 (USD MILLION)
TABLE 183 ASIA PACIFIC: BETA-GLUCAN COSMETICS MARKET, BY FORM, 2019–2023 (USD MILLION)
TABLE 184 ASIA PACIFIC: BETA-GLUCAN COSMETICS MARKET, BY FORM, 2024–2029 (USD MILLION)
TABLE 185 ASIA PACIFIC: BETA-GLUCAN COSMETICS MARKET, BY FUNCTIONALITY, 2019–2023 (USD MILLION)
TABLE 186 ASIA PACIFIC: BETA-GLUCAN COSMETICS MARKET, BY FUNCTIONALITY, 2024–2029 (USD MILLION)
TABLE 187 ASIA PACIFIC: BETA-GLUCAN ANIMAL FEED MARKET, BY SUB-APPLICATION, 2019–2023 (USD MILLION)
TABLE 188 ASIA PACIFIC: BETA-GLUCAN ANIMAL FEED MARKET, BY SUB-APPLICATION, 2024–2029 (USD MILLION)
13.4.2 CHINA
13.4.2.1 Higher demand for high-quality processed foods and presence of major vendors to foster market growth
TABLE 189 CHINA: BETA-GLUCAN MARKET, BY CATEGORY, 2019–2023 (USD MILLION)
TABLE 190 CHINA: BETA-GLUCAN MARKET, BY CATEGORY, 2024–2029 (USD MILLION)
TABLE 191 CHINA: BETA-GLUCAN MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 192 CHINA: BETA-GLUCAN MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
13.4.3 JAPAN
13.4.3.1 Rise in healthcare costs and higher life expectancy due to preventive healthcare measures to drive market
TABLE 193 JAPAN: BETA-GLUCAN MARKET, BY CATEGORY, 2019–2023 (USD MILLION)
TABLE 194 JAPAN: BETA-GLUCAN MARKET, BY CATEGORY, 2024–2029 (USD MILLION)
TABLE 195 JAPAN: BETA-GLUCAN MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 196 JAPAN: BETA-GLUCAN MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
13.4.4 INDIA
13.4.4.1 Promotion of innovation and product development in food industry to fuel demand for beta-glucan
TABLE 197 INDIA: BETA-GLUCAN MARKET, BY CATEGORY, 2019–2023 (USD MILLION)
TABLE 198 INDIA: BETA-GLUCAN MARKET, BY CATEGORY, 2024–2029 (USD MILLION)
TABLE 199 INDIA: BETA-GLUCAN MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 200 INDIA: BETA-GLUCAN MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
13.4.5 AUSTRALIA & NEW ZEALAND
13.4.5.1 Need to promote animal growth, boost immunity, and improve overall productivity to propel market
TABLE 201 AUSTRALIA & NEW ZEALAND: BETA-GLUCAN MARKET, BY CATEGORY, 2019–2023 (USD MILLION)
TABLE 202 AUSTRALIA & NEW ZEALAND: BETA-GLUCAN MARKET, BY CATEGORY, 2024–2029 (USD MILLION)
TABLE 203 AUSTRALIA & NEW ZEALAND: BETA-GLUCAN MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 204 AUSTRALIA & NEW ZEALAND: BETA-GLUCAN MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
13.4.6 REST OF ASIA PACIFIC
TABLE 205 REST OF ASIA PACIFIC: BETA-GLUCAN MARKET, BY CATEGORY, 2019–2023 (USD MILLION)
TABLE 206 REST OF ASIA PACIFIC: BETA-GLUCAN MARKET, BY CATEGORY, 2024–2029 (USD MILLION)
TABLE 207 REST OF ASIA PACIFIC: BETA-GLUCAN MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 208 REST OF ASIA PACIFIC: BETA-GLUCAN MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
13.5 SOUTH AMERICA
13.5.1 SOUTH AMERICA: RECESSION IMPACT ANALYSIS
FIGURE 60 SOUTH AMERICA: COUNTRY-LEVEL DATA FOR INFLATION, 2017–2022
FIGURE 61 SOUTH AMERICA BETA-GLUCAN MARKET: RECESSION IMPACT ANALYSIS
TABLE 209 SOUTH AMERICA: BETA-GLUCAN MARKET, BY COUNTRY, 2019–2023 (USD MILLION)
TABLE 210 SOUTH AMERICA: BETA-GLUCAN MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
TABLE 211 SOUTH AMERICA: BETA-GLUCAN MARKET, BY SOURCE, 2019–2023 (USD MILLION)
TABLE 212 SOUTH AMERICA: BETA-GLUCAN MARKET, BY SOURCE, 2024–2029 (USD MILLION)
TABLE 213 SOUTH AMERICA: BETA-GLUCAN MARKET, BY SOURCE, 2019–2023 (TONS)
TABLE 214 SOUTH AMERICA: BETA-GLUCAN MARKET, BY SOURCE, 2024–2029 (TONS)
TABLE 215 SOUTH AMERICA: BETA-GLUCAN MARKET, BY CATEGORY, 2019–2023 (USD MILLION)
TABLE 216 SOUTH AMERICA: BETA-GLUCAN MARKET, BY CATEGORY, 2024–2029 (USD MILLION)
TABLE 217 SOUTH AMERICA: BETA-GLUCAN MARKET, BY TYPE, 2019–2023 (USD MILLION)
TABLE 218 SOUTH AMERICA: BETA-GLUCAN MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 219 SOUTH AMERICA: BETA-GLUCAN MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 220 SOUTH AMERICA: BETA-GLUCAN MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 221 SOUTH AMERICA: BETA-GLUCAN PERSONAL CARE MARKET, BY FORM, 2019–2023 (USD MILLION)
TABLE 222 SOUTH AMERICA: BETA-GLUCAN PERSONAL CARE MARKET, BY FORM, 2024–2029 (USD MILLION)
TABLE 223 SOUTH AMERICA: BETA-GLUCAN PERSONAL CARE MARKET, BY FUNCTIONALITY, 2019–2023 (USD MILLION)
TABLE 224 SOUTH AMERICA: BETA-GLUCAN PERSONAL CARE MARKET, BY FUNCTIONALITY, 2024–2029 (USD MILLION)
TABLE 225 SOUTH AMERICA: BETA-GLUCAN COSMETICS MARKET, BY FORM, 2019–2023 (USD MILLION)
TABLE 226 SOUTH AMERICA: BETA-GLUCAN COSMETICS MARKET, BY FORM, 2024–2029 (USD MILLION)
TABLE 227 SOUTH AMERICA: BETA-GLUCAN COSMETICS MARKET, BY FUNCTIONALITY, 2019–2023 (USD MILLION)
TABLE 228 SOUTH AMERICA: BETA-GLUCAN COSMETICS MARKET, BY FUNCTIONALITY, 2024–2029 (USD MILLION)
TABLE 229 SOUTH AMERICA: BETA-GLUCAN ANIMAL FEED MARKET, BY SUB-APPLICATION, 2019–2023 (USD MILLION)
TABLE 230 SOUTH AMERICA: BETA-GLUCAN ANIMAL FEED MARKET, BY SUB-APPLICATION, 2024–2029 (USD MILLION)
13.5.2 BRAZIL
13.5.2.1 Rising geriatric population, surge in obesity levels, urbanization, and health consciousness to spur market growth
TABLE 231 BRAZIL: BETA-GLUCAN MARKET, BY CATEGORY, 2019–2023 (USD MILLION)
TABLE 232 BRAZIL: BETA-GLUCAN MARKET, BY CATEGORY, 2024–2029 (USD MILLION)
TABLE 233 BRAZIL: BETA-GLUCAN MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 234 BRAZIL: BETA-GLUCAN MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
13.5.3 ARGENTINA
13.5.3.1 Need for reducing cholesterol levels and promoting digestion to fuel demand for oats-derived beta-glucan
TABLE 235 ARGENTINA: BETA-GLUCAN MARKET, BY CATEGORY, 2019–2023 (USD MILLION)
TABLE 236 ARGENTINA: BETA-GLUCAN MARKET, BY CATEGORY, 2024–2029 (USD MILLION)
TABLE 237 ARGENTINA: BETA-GLUCAN MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 238 ARGENTINA: BETA-GLUCAN MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
13.5.4 REST OF SOUTH AMERICA
TABLE 239 REST OF SOUTH AMERICA: BETA-GLUCAN MARKET, BY CATEGORY, 2019–2023 (USD MILLION)
TABLE 240 REST OF SOUTH AMERICA: BETA-GLUCAN MARKET, BY CATEGORY, 2024–2029 (USD MILLION)
TABLE 241 REST OF SOUTH AMERICA: BETA-GLUCAN MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 242 REST OF SOUTH AMERICA: BETA-GLUCAN MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
13.6 REST OF THE WORLD (ROW)
13.6.1 ROW: RECESSION IMPACT ANALYSIS
FIGURE 62 ROW: KEY COUNTRY-WISE INFLATION RATES, 2017–2022
FIGURE 63 ROW: RECESSION IMPACT ANALYSIS, 2023
TABLE 243 ROW: BETA-GLUCAN MARKET, BY COUNTRY, 2019–2023 (USD MILLION)
TABLE 244 ROW: BETA-GLUCAN MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
TABLE 245 ROW: BETA-GLUCAN MARKET, BY SOURCE, 2019–2023 (USD MILLION)
TABLE 246 ROW: BETA-GLUCAN MARKET, BY SOURCE, 2024–2029 (USD MILLION)
TABLE 247 ROW: BETA-GLUCAN MARKET, BY SOURCE, 2019–2023 (TONS)
TABLE 248 ROW: BETA-GLUCAN MARKET, BY SOURCE, 2024–2029 (TONS)
TABLE 249 ROW: BETA-GLUCAN MARKET, BY CATEGORY, 2019–2023 (USD MILLION)
TABLE 250 ROW: BETA-GLUCAN MARKET, BY CATEGORY, 2024–2029 (USD MILLION)
TABLE 251 ROW: BETA-GLUCAN MARKET, BY TYPE, 2019–2023 (USD MILLION)
TABLE 252 ROW: BETA-GLUCAN MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 253 ROW: BETA-GLUCAN MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 254 ROW: BETA-GLUCAN MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 255 ROW: BETA-GLUCAN PERSONAL CARE MARKET, BY FORM, 2019–2023 (USD MILLION)
TABLE 256 ROW: BETA-GLUCAN PERSONAL CARE MARKET, BY FORM, 2024–2029 (USD MILLION)
TABLE 257 ROW: BETA-GLUCAN PERSONAL CARE MARKET, BY FUNCTIONALITY, 2019–2023 (USD MILLION)
TABLE 258 ROW: BETA-GLUCAN PERSONAL CARE MARKET, BY FUNCTIONALITY, 2024–2029 (USD MILLION)
TABLE 259 ROW: BETA-GLUCAN COSMETICS MARKET, BY FORM, 2019–2023 (USD MILLION)
TABLE 260 ROW: BETA-GLUCAN COSMETICS MARKET, BY FORM, 2024–2029 (USD MILLION)
TABLE 261 ROW: BETA-GLUCAN COSMETICS MARKET, BY FUNCTIONALITY, 2019–2023 (USD MILLION)
TABLE 262 ROW: BETA-GLUCAN COSMETICS MARKET, BY FUNCTIONALITY, 2024–2029 (USD MILLION)
TABLE 263 ROW: BETA-GLUCAN ANIMAL FEED MARKET, BY SUB-APPLICATION, 2019–2023 (USD MILLION)
TABLE 264 ROW: BETA-GLUCAN ANIMAL FEED MARKET, BY SUB-APPLICATION, 2024–2029 (USD MILLION)
13.6.2 MIDDLE EAST
13.6.2.1 Expanding middle-class population and industrial growth and increased health and wellness initiatives in Middle East to drive market
TABLE 265 MIDDLE EAST: BETA-GLUCAN MARKET, BY CATEGORY, 2019–2023 (USD MILLION)
TABLE 266 MIDDLE EAST: BETA-GLUCAN MARKET, BY CATEGORY, 2024–2029 (USD MILLION)
TABLE 267 MIDDLE EAST: BETA-GLUCAN MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 268 MIDDLE EAST: BETA-GLUCAN MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
13.6.3 AFRICA
13.6.3.1 Growing demand for natural and functional ingredients to boost demand for beta-glucan ingredients
TABLE 269 AFRICA: BETA-GLUCAN MARKET, BY CATEGORY, 2019–2023 (USD MILLION)
TABLE 270 AFRICA: BETA-GLUCAN MARKET, BY CATEGORY, 2024–2029 (USD MILLION)
TABLE 271 AFRICA: BETA-GLUCAN MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 272 AFRICA: BETA-GLUCAN MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
14 COMPETITIVE LANDSCAPE
14.1 OVERVIEW
14.2 REVENUE ANALYSIS
FIGURE 64 SEGMENTAL REVENUE ANALYSIS OF KEY PLAYERS, 2019–2023 (USD BILLION)
14.3 MARKET SHARE ANALYSIS
TABLE 273 BETA-GLUCAN MARKET: MARKET SHARE ANALYSIS, 2023
14.4 KEY PLAYER STRATEGIES/RIGHT TO WIN
TABLE 274 OVERVIEW OF STRATEGIES ADOPTED BY KEY BETA-GLUCAN PLAYERS
14.5 COMPANY VALUATION AND FINANCIAL METRICS
FIGURE 65 COMPANY VALUATION
FIGURE 66 EV/EBITDA OF FEW MAJOR PLAYERS
14.6 BRAND/PRODUCT COMPARISON ANALYSIS
FIGURE 67 BETA-GLUCAN MARKET: BRAND/PRODUCT COMPARISON ANALYSIS
14.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
14.7.1 STARS
14.7.2 EMERGING LEADERS
14.7.3 PERVASIVE PLAYERS
14.7.4 PARTICIPANTS
FIGURE 68 BETA-GLUCAN MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2023
14.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
14.7.5.1 Company footprint
FIGURE 69 OVERALL COMPANY FOOTPRINT
14.7.5.2 Regional footprint
TABLE 275 REGIONAL FOOTPRINT
14.7.5.3 Source footprint
TABLE 276 SOURCE FOOTPRINT
14.7.5.4 Application footprint
TABLE 277 APPLICATION FOOTPRINT
14.7.5.5 Type footprint
TABLE 278 TYPE FOOTPRINT
14.8 COMPANY EVALUATION MATRIX: START-UPS/SMES, 2023
14.8.1 PROGRESSIVE COMPANIES
14.8.2 RESPONSIVE COMPANIES
14.8.3 DYNAMIC COMPANIES
14.8.4 STARTING BLOCKS
FIGURE 70 BETA-GLUCAN MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2023
14.8.5 COMPETITIVE BENCHMARKING, START-UPS/SMES, 2023
14.8.5.1 Detailed list of key start-ups/SMEs
TABLE 279 BETA-GLUCAN MARKET: LIST OF KEY START-UPS/SMES
14.8.5.2 Competitive benchmarking of key start-ups/SMEs
TABLE 280 BETA-GLUCAN MARKET: COMPETITIVE BENCHMARKING OF START-UPS/SMES
14.9 COMPETITIVE SCENARIO AND TRENDS
14.9.1 DEALS
TABLE 281 BETA-GLUCAN MARKET: DEALS, 2020–2022
14.9.2 EXPANSIONS
TABLE 282 BETA-GLUCAN MARKET: EXPANSIONS, 2019–2022
15 COMPANY PROFILES
(Business Overview, Products/Solutions Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
15.1 KEY PLAYERS
15.1.1 TATE & LYLE PLC
TABLE 283 TATE & LYLE PLC: BUSINESS OVERVIEW
FIGURE 71 TATE & LYLE PLC: COMPANY SNAPSHOT
TABLE 284 TATE & LYLE PLC: INGREDIENTS OFFERED
TABLE 285 TATE & LYLE PLC: DEALS
TABLE 286 TATE & LYLE PLC: EXPANSIONS
TABLE 287 TATE & LYLE PLC: OTHER DEVELOPMENTS
15.1.2 KERRY GROUP PLC
TABLE 288 KERRY GROUP PLC: BUSINESS OVERVIEW
FIGURE 72 KERRY GROUP PLC: COMPANY SNAPSHOT
TABLE 289 KERRY GROUP PLC: INGREDIENTS OFFERED
15.1.3 DSM-FIRMENICH
TABLE 290 DSM-FIRMENICH: BUSINESS OVERVIEW
FIGURE 73 DSM-FIRMENICH: COMPANY SNAPSHOT
TABLE 291 DSM-FIRMENICH: INGREDIENTS OFFERED
TABLE 292 DSM-FIRMENICH: EXPANSIONS
15.1.4 ANGEL YEAST CO., LTD.
TABLE 293 ANGEL YEAST CO., LTD.: BUSINESS OVERVIEW
FIGURE 74 ANGEL YEAST CO., LTD: COMPANY SNAPSHOT
TABLE 294 ANGEL YEAST CO., LTD.: INGREDIENTS OFFERED
TABLE 295 ANGEL YEAST CO., LTD.: PRODUCTS OFFERED
TABLE 296 ANGEL YEAST CO., LTD.: EXPANSIONS
15.1.5 MERCK
TABLE 297 MERCK: BUSINESS OVERVIEW
FIGURE 75 MERCK: COMPANY SNAPSHOT
TABLE 298 MERCK: INGREDIENTS OFFERED
TABLE 299 MERCK: EXPANSIONS
15.1.6 ASSOCIATED BRITISH FOODS PLC
TABLE 300 ASSOCIATED BRITISH FOODS PLC: BUSINESS OVERVIEW
FIGURE 76 ASSOCIATED BRITISH FOODS PLC: COMPANY SNAPSHOT
TABLE 301 ASSOCIATED BRITISH FOODS PLC: INGREDIENTS OFFERED
TABLE 302 ASSOCIATED BRITISH FOODS PLC: PRODUCTS OFFERED
15.1.7 CEAPRO INC.
TABLE 303 CEAPRO INC.: BUSINESS OVERVIEW
FIGURE 77 CEAPRO INC.: COMPANY SNAPSHOT
TABLE 304 CEAPRO INC.: INGREDIENTS OFFERED
TABLE 305 CEAPRO INC.: DEALS
TABLE 306 CEAPRO INC.: OTHER DEVELOPMENTS
15.1.8 LESAFFRE
TABLE 307 LESAFFRE: BUSINESS OVERVIEW
TABLE 308 LESAFFRE: INGREDIENTS OFFERED
TABLE 309 LESAFFRE: PRODUCTS OFFERED
TABLE 310 LESAFFRE: DEALS
15.1.9 KEMIN INDUSTRIES, INC.
TABLE 311 KEMIN INDUSTRIES, INC.: BUSINESS OVERVIEW
TABLE 312 KEMIN INDUSTRIES, INC.: INGREDIENTS OFFERED
TABLE 313 KEMIN INDUSTRIES, INC.: EXPANSIONS
TABLE 314 KEMIN INDUSTRIES, INC.: OTHER DEVELOPMENTS
15.1.10 FOODCHEM INTERNATIONAL CORPORATION
TABLE 315 FOODCHEM INTERNATIONAL CORPORATION: BUSINESS OVERVIEW
TABLE 316 FOODCHEM INTERNATIONAL CORPORATION: INGREDIENTS OFFERED
15.1.11 LALLEMAND
TABLE 317 LALLEMAND: BUSINESS OVERVIEW
TABLE 318 LALLEMAND: INGREDIENTS OFFERED
TABLE 319 LALLEMAND: PRODUCTS OFFERED
TABLE 320 LALLEMAND: DEALS
15.1.12 BIORIGIN
TABLE 321 BIORIGIN: BUSINESS OVERVIEW
TABLE 322 BIORIGIN: INGREDIENTS OFFERED
15.1.13 NUTRISCIENCE INNOVATIONS, LLC
TABLE 323 NUTRISCIENCE INNOVATIONS, LLC: BUSINESS OVERVIEW
TABLE 324 NUTRISCIENCE INNOVATIONS, LLC: INGREDIENTS OFFERED
15.1.14 LEIBER
TABLE 325 LEIBER: BUSINESS OVERVIEW
TABLE 326 LEIBER: INGREDIENTS OFFERED
TABLE 327 LEIBER: PRODUCTS OFFERED
15.1.15 GARUDA INTERNATIONAL INC.
TABLE 328 GARUDA INTERNATIONAL INC.: BUSINESS OVERVIEW
TABLE 329 GARUDA INTERNATIONAL INC.: INGREDIENTS OFFERED
15.2 OTHER PLAYERS
15.2.1 VW-INGREDIENTS
TABLE 330 VW-INGREDIENTS: BUSINESS OVERVIEW
TABLE 331 VW-INGREDIENTS: INGREDIENTS OFFERED
15.2.2 SUPER BETA GLUCAN
TABLE 332 SUPER BETA GLUCAN: BUSINESS OVERVIEW
TABLE 333 SUPER BETA GLUCAN: INGREDIENTS OFFERED
15.2.3 GLYCANOVA AS
TABLE 334 GLYCANOVA AS: BUSINESS OVERVIEW
TABLE 335 GLYCANOVA AS: INGREDIENTS OFFERED
TABLE 336 GLYCANOVA AS: PRODUCTS OFFERED
15.2.4 SPECIALTY BIOTECH CO., LTD.
TABLE 337 SPECIALTY BIOTECH CO., LTD.: BUSINESS OVERVIEW
TABLE 338 SPECIALTY BIOTECH CO., LTD.: INGREDIENTS OFFERED
15.2.5 ALGALНF ICELAND HF.
TABLE 339 ALGALНF ICELAND HF.: BUSINESS OVERVIEW
TABLE 340 ALGALНF ICELAND HF.: INGREDIENTS OFFERED
15.2.6 NATURAL BIOLOGICS
TABLE 341 NATURAL BIOLOGICS: BUSINESS OVERVIEW
15.2.7 ABAC R&D AG
TABLE 342 ABAC R&D AG: BUSINESS OVERVIEW
15.2.8 BENEO
TABLE 343 BENEO: BUSINESS OVERVIEW
15.2.9 L&P FOOD INGREDIENT CO., LTD
TABLE 344 L&P FOOD INGREDIENT CO., LTD: BUSINESS OVERVIEW
15.2.10 BETA BIO TECHNOLOGY SP. Z O. O.
TABLE 345 BETA BIO TECHNOLOGY SP. Z O. O. : BUSINESS OVERVIEW
15.3 PRODUCT-BASED COMPANIES
15.3.1 CARGILL, INCORPORATED
TABLE 346 CARGILL, INCORPORATED: BUSINESS OVERVIEW
15.3.2 INTERNATIONAL FLAVORS & FRAGRANCES, INC.
TABLE 347 INTERNATIONAL FLAVORS & FRAGRANCES, INC.: BUSINESS OVERVIEW
15.3.3 VIVESA HOLDING S.R.O
TABLE 348 VIVESA HOLDING S.R.O: BUSINESS OVERVIEW
15.3.4 ALERIS
TABLE 349 ALERIS: BUSINESS OVERVIEW
15.3.5 ICC
TABLE 350 ICC: BUSINESS OVERVIEW
15.3.6 PROSOL S.P.A.
TABLE 351 PROSOL S.P.A.: BUSINESS OVERVIEW
15.3.7 ABN APLICACIONES BIOLУGICAS A LA NUTRICIУN
TABLE 352 ABN APLICACIONES BIOLУGICAS A LA NUTRICIУN: BUSINESS OVERVIEW
15.3.8 EW NUTRITION
TABLE 353 EW NUTRITION: BUSINESS OVERVIEW
15.3.9 BIOCHEM ZUSATZSTOFFE HANDELS- UND PRODUKTIONSGESELLSCHAFT MBH
TABLE 354 BIOCHEM ZUSATZSTOFFE HANDELS- UND PRODUKTIONSGESELLSCHAFT MBH: BUSINESS OVERVIEW
15.3.10 MIBELLE BIOCHEMISTRY
TABLE 355 MIBELLE BIOCHEMISTRY: BUSINESS OVERVIEW
*Details on Business Overview, Products/Solutions Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
16 ADJACENT & RELATED MARKETS
16.1 INTRODUCTION
TABLE 356 ADJACENT MARKETS
16.2 STUDY LIMITATIONS
16.3 YEAST MARKET
16.3.1 MARKET DEFINITION
16.3.2 MARKET OVERVIEW
TABLE 357 YEAST MARKET, BY TYPE, 2019–2023 (USD MILLION)
TABLE 358 YEAST MARKET, BY TYPE, 2024–2029 (USD MILLION)
16.4 STARTER CULTURE MARKET
16.4.1 MARKET DEFINITION
16.4.2 MARKET OVERVIEW
TABLE 359 STARTER CULTURE MARKET, BY APPLICATION, 2017–2021 (USD MILLION)
TABLE 360 STARTER CULTURE MARKET, BY APPLICATION, 2022–2027 (USD MILLION)
17 APPENDIX
17.1 DISCUSSION GUIDE
17.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
17.3 CUSTOMIZATION OPTIONS
17.4 RELATED REPORTS
17.5 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKET SEGMENTATION
1.3.2 INCLUSIONS AND EXCLUSIONS
1.3.3 REGIONS COVERED
1.3.4 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
TABLE 1 USD EXCHANGE RATES, 2019–2023
1.5 UNIT CONSIDERED
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
1.7.1 IMPACT OF RECESSION
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 1 BETA-GLUCAN MARKET: RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 Breakdown of primary profiles
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.1.2.3 Key insights from industry experts
2.2 MARKET SIZE ESTIMATION
2.2.1 TOP-DOWN APPROACH
FIGURE 3 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
2.2.2 SUPPLY-SIDE ANALYSIS
FIGURE 4 BETA-GLUCAN MARKET SIZE CALCULATION: SUPPLY SIDE
2.2.3 BOTTOM-UP APPROACH (DEMAND SIDE)
FIGURE 5 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
2.3 DATA TRIANGULATION AND MARKET BREAKUP
FIGURE 6 DATA TRIANGULATION
2.4 RESEARCH ASSUMPTIONS
2.5 LIMITATIONS AND RISK ASSESSMENT
2.6 RECESSION IMPACT ANALYSIS
2.6.1 MACRO-INDICATORS OF RECESSION
FIGURE 7 RECESSION INDICATORS
FIGURE 8 GLOBAL INFLATION RATE, 2011–2022
FIGURE 9 GLOBAL GDP, 2011–2022 (USD TRILLION)
FIGURE 10 RECESSION INDICATORS AND THEIR IMPACT ON BETA-GLUCAN MARKET
FIGURE 11 GLOBAL BETA-GLUCAN MARKET: EARLIER FORECAST VS. RECESSION FORECAST
3 EXECUTIVE SUMMARY
TABLE 2 BETA-GLUCAN MARKET SHARE SNAPSHOT, 2024 VS. 2029 (USD MILLION)
FIGURE 12 BETA-GLUCAN MARKET, BY SOURCE, 2024 VS. 2029 (USD MILLION)
FIGURE 13 BETA-GLUCAN MARKET, BY CATEGORY, 2024 VS. 2029 (USD MILLION)
FIGURE 14 BETA-GLUCAN MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
FIGURE 15 BETA-GLUCAN MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
FIGURE 16 BETA-GLUCAN MARKET SHARE AND GROWTH RATE, BY REGION, 2024 (BY VALUE)
4 PREMIUM INSIGHTS
4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN BETA-GLUCAN MARKET
FIGURE 17 CONSUMER PREFERENCES FOR HEALTHY AND NUTRITIONAL PROTEIN TO DRIVE BETA-GLUCAN MARKET
4.2 ASIA PACIFIC: BETA-GLUCAN MARKET, BY CATEGORY AND COUNTRY
FIGURE 18 CHINA AND SOLUBLE SEGMENT TO ACCOUNT FOR SIGNIFICANT SHARES IN 2024
4.3 BETA-GLUCAN MARKET, BY TYPE
FIGURE 19 (1,3 BETA-GLUCAN) SEGMENT TO ACCOUNT FOR LARGEST MARKET DURING FORECAST PERIOD
4.4 BETA-GLUCAN MARKET, BY SOURCE
FIGURE 20 CEREALS & GRAINS SEGMENT TO LARGEST MARKET DURING FORECAST PERIOD
4.5 BETA-GLUCAN MARKET, BY CATEGORY
FIGURE 21 SOLUBLE SEGMENT TO ACCOUNT FOR LARGER MARKET DURING FORECAST PERIOD
4.6 BETA-GLUCAN MARKET, BY APPLICATION
FIGURE 22 FOOD & BEVERAGES SEGMENT TO ACCOUNT FOR LARGEST MARKET DURING FORECAST PERIOD
4.7 BETA-GLUCAN MARKET, BY CATEGORY AND REGION
FIGURE 23 SOLUBLE SEGMENT TO LEAD ACROSS ALL REGIONAL MARKETS DURING FORECAST PERIOD
4.8 BETA-GLUCAN MARKET: REGIONAL SNAPSHOT
FIGURE 24 US TO DOMINATE BETA-GLUCAN MARKET IN 2024
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MACROECONOMIC INDICATORS
5.2.1 RISING GLOBAL DOMESTIC PRODUCT AND POPULATION GROWTH TO DRIVE APPETITE FOR BETA-GLUCAN
FIGURE 25 GLOBAL POPULATION GROWTH, 1950–2050 (BILLION)
FIGURE 26 GDP GROWTH, 2016–2022 (TRILLION)
5.2.2 RISING HEALTH CONCERNS AND GROWTH IN DISEASES
FIGURE 27 PERCENTAGE POPULATION OF CANCER PATIENTS, BY REGION, 2022
5.2.3 INCREASE IN CONSUMPTION OF DIETARY FIBERS
5.3 MARKET DYNAMICS
FIGURE 28 BETA-GLUCAN MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.3.1 DRIVERS
5.3.1.1 Growth in health consciousness and increasing health expenditure
FIGURE 29 GLOBAL OECD HEALTH SPENDING AS SHARE OF GLOBAL DOMESTIC PRODUCT, 2017–2021
5.3.1.2 Increasing research and application of beta-glucan in fast-moving industries
5.3.2 RESTRAINTS
5.3.2.1 Inconsistency in regulatory norms governing beta-glucan
5.3.2.2 Price volatility of raw materials
5.3.3 OPPORTUNITIES
5.3.3.1 Growing demand for natural and plant-based ingredients
5.3.3.2 Demand for personalized nutrition and tailored beta-glucan products
5.3.3.3 Untapped beta-glucan applications
5.3.4 CHALLENGES
5.3.4.1 Lack of consumer awareness regarding benefits of beta-glucan
5.3.4.2 High research and development costs
6 INDUSTRY TRENDS
6.1 INTRODUCTION
6.2 SUPPLY CHAIN ANALYSIS
FIGURE 30 BETA-GLUCAN MARKET: SUPPLY CHAIN ANALYSIS
6.3 VALUE CHAIN ANALYSIS
FIGURE 31 BETA-GLUCAN MARKET: VALUE CHAIN ANALYSIS
6.3.1 RESEARCH & DEVELOPMENT
6.3.2 RAW MATERIAL SOURCING
6.3.3 PRODUCTION
6.3.4 DISTRIBUTION
6.3.5 END USERS
6.4 TRADE ANALYSIS
6.4.1 IMPORT SCENARIO OF YEAST
FIGURE 32 HS CODE 2102: IMPORT VALUE OF YEAST, BY KEY COUNTRY, 2019–2023
TABLE 3 HS CODE 2102: IMPORT SCENARIO OF YEAST, BY COUNTRY, 2022 (USD)
6.4.2 EXPORT SCENARIO OF YEAST
FIGURE 33 HS CODE 2102: EXPORT VALUE OF YEAST, BY KEY COUNTRY, 2019–2023
TABLE 4 HS CODE 2102: EXPORT SCENARIO OF YEAST, BY COUNTRY, 2022 (USD)
6.4.3 IMPORT SCENARIO OF MUSHROOMS
FIGURE 34 HS CODE 2003: IMPORT VALUE OF MUSHROOMS, BY KEY COUNTRY, 2019–2023
TABLE 5 HS CODE 2003: IMPORT SCENARIO OF MUSHROOMS, BY COUNTRY, 2022 (USD)
6.4.4 EXPORT SCENARIO OF MUSHROOMS
FIGURE 35 HS CODE 2003: EXPORT VALUE OF MUSHROOMS, BY KEY COUNTRY, 2019–2023
TABLE 6 HS CODE 2003: EXPORT SCENARIO OF MUSHROOMS, BY COUNTRY, 2022 (USD)
6.4.5 IMPORT SCENARIO OF OATS
FIGURE 36 HS CODE 1004: IMPORT VALUE OF OATS, BY KEY COUNTRY, 2019–2023
TABLE 7 HS CODE 1004: IMPORT SCENARIO OF OATS, BY COUNTRY, 2022 (USD)
6.4.6 EXPORT SCENARIO OF OATS
FIGURE 37 HS CODE 1004: EXPORT VALUE OF OATS, BY KEY COUNTRY, 2019–2023
TABLE 8 HS CODE 1004: EXPORT SCENARIO OF OATS, BY COUNTRY, 2022 (USD)
6.4.7 IMPORT SCENARIO OF BARLEY
FIGURE 38 HS CODE 1003: IMPORT VALUE OF BARLEY, BY KEY COUNTRY, 2019–2023
TABLE 9 HS CODE 1003: IMPORT SCENARIO OF BARLEY, BY COUNTRY, 2022 (USD)
6.4.8 EXPORT SCENARIO OF BARLEY
FIGURE 39 HS CODE 1003: EXPORT VALUE OF BARLEY, BY KEY COUNTRY, 2019–2023
TABLE 10 HS CODE 1003: EXPORT SCENARIO OF BARLEY, BY COUNTRY, 2022 (USD)
6.5 TECHNOLOGY ANALYSIS
6.5.1 KEY TECHNOLOGIES
6.5.1.1 Encapsulation
6.5.2 COMPLEMENTARY TECHNOLOGIES
6.5.2.1 High-purity yeast beta-glucan technology
6.5.3 ADJACENT TECHNOLOGIES
6.5.3.1 New avenues for yeast culture and extraction
6.6 PRICING ANALYSIS
6.6.1 AVERAGE SELLING PRICE TREND, BY REGION
TABLE 11 BETA-GLUCAN MARKET: AVERAGE SELLING PRICE TREND, BY REGION, 2023–2029 (USD/TONS)
6.6.2 AVERAGE SELLING PRICE TREND, BY SOURCE
TABLE 12 BETA-GLUCAN MARKET: AVERAGE SELLING PRICE TREND, BY SOURCE, 2023–2029 (USD/TONS)
FIGURE 40 AVERAGE SELLING PRICE TREND, BY SOURCE (USD/TONS)
6.7 ECOSYSTEM/MARKET MAP
6.7.1 DEMAND SIDE
6.7.2 SUPPLY SIDE
FIGURE 41 KEY PLAYERS IN BETA-GLUCAN MARKET ECOSYSTEM
TABLE 13 BETA-GLUCAN MARKET: ECOSYSTEM
6.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 42 REVENUE SHIFT FOR BETA-GLUCAN MARKET VENDORS
6.9 PATENT ANALYSIS
TABLE 14 LIST OF MAJOR PATENTS PERTAINING TO BETA-GLUCAN MARKET, 2014–2024
FIGURE 43 NUMBER OF PATENTS GRANTED FOR BETA-GLUCAN, 2014–2023
FIGURE 44 REGIONAL ANALYSIS OF PATENTS GRANTED FOR BETA-GLUCAN
6.10 KEY CONFERENCES AND EVENTS
TABLE 15 BETA-GLUCAN MARKET: LIST OF KEY CONFERENCES AND EVENTS, 2024
6.11 REGULATORY LANDSCAPE
6.11.1 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
6.11.1.1 North America
TABLE 16 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
6.11.1.2 Europe
TABLE 17 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
6.11.1.3 Asia Pacific
TABLE 18 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
6.11.1.4 RoW
TABLE 19 ROW: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
6.11.2 REGULATORY FRAMEWORK
6.11.2.1 Introduction
6.11.2.2 North America
6.11.2.2.1 US Food and Drug Administration (21CFR101.14)
6.11.2.2.2 US Food and Drug Administration (21CFR101.81)
6.11.2.3 European Food Safety Authority
6.11.2.3.1 European Union
6.12 PORTER’S FIVE FORCES’ ANALYSIS
TABLE 20 PORTER’S FIVE FORCES’ IMPACT ON BETA-GLUCAN MARKET
6.12.1 THREAT OF NEW ENTRANTS
6.12.2 THREAT OF SUBSTITUTES
6.12.3 BARGAINING POWER OF SUPPLIERS
6.12.4 BARGAINING POWER OF BUYERS
6.12.5 INTENSITY OF COMPETITIVE RIVALRY
6.13 KEY STAKEHOLDERS AND BUYING CRITERIA
6.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 45 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP APPLICATIONS
TABLE 21 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP APPLICATIONS
6.13.2 BUYING CRITERIA
TABLE 22 KEY BUYING CRITERIA FOR TOP APPLICATIONS
FIGURE 46 KEY BUYING CRITERIA FOR TOP APPLICATIONS
6.14 CASE STUDY ANALYSIS
6.14.1 CARGILL INVESTED USD 35 MILLION TO PRODUCE SOLUBLE FIBERS THAT MEET CONSUMER DEMAND FOR HEALTHY PRODUCTS
6.14.2 TATE & LYLE ENTERED INTO PARTNERSHIP WITH SOLEVO TO DISTRIBUTE WIDE RANGE OF PRODUCTS AND TAP UNTAPPED OPPORTUNITIES
6.15 BETA-GLUCAN PURITY ANALYSIS
6.15.1 ACIDIC EXTRACTION
6.15.2 ALKALINE EXTRACTION
6.15.3 WATER EXTRACTION
6.15.4 ENZYMATIC EXTRACTION
7 BETA-GLUCAN MARKET, BY EXTRACTION METHOD
7.1 INTRODUCTION
TABLE 23 BETA-GLUCAN YIELDS AND PRODUCTION TECHNOLOGIES FROM VARIOUS SOURCES
7.2 BETA-GLUCAN FROM CEREALS
7.3 BETA-GLUCAN FROM YEAST
8 BETA-GLUCAN MARKET, BY APPLICATION
8.1 INTRODUCTION
TABLE 24 APPLICATION OVERVIEW
FIGURE 47 BETA-GLUCAN MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
TABLE 25 BETA-GLUCAN MARKET: BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 26 BETA-GLUCAN MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
8.2 FOOD & BEVERAGES
8.2.1 INCREASING AWARENESS OF HEALTH BENEFITS IN PREVENTING AND MANAGING CHRONIC DISEASES TO DRIVE DEMAND FOR BETA-GLUCAN
TABLE 27 FOOD & BEVERAGES: BETA-GLUCAN MARKET, BY REGION, 2019–2023 (USD MILLION)
TABLE 28 FOOD & BEVERAGES: BETA-GLUCAN MARKET, BY REGION, 2024–2029 (USD MILLION)
8.3 PERSONAL CARE
8.3.1 GROWING CONSUMER DEMAND FOR NATURAL AND HEALTHY PRODUCTS AND AWARENESS REGARDING SKIN HEALTH TO PROPEL MARKET
TABLE 29 PERSONAL CARE: BETA-GLUCAN MARKET, BY REGION, 2019–2023 (USD MILLION)
TABLE 30 PERSONAL CARE: BETA-GLUCAN MARKET, BY REGION, 2024–2029 (USD MILLION)
8.3.1.1 By form
8.3.1.1.1 Creams
8.3.1.1.2 Lotions
8.3.1.1.3 Other personal care forms
TABLE 31 PERSONAL CARE: BETA-GLUCAN MARKET, BY FORM, 2019–2023 (USD MILLION)
TABLE 32 PERSONAL CARE: BETA-GLUCAN MARKET, BY FORM, 2024–2029 (USD MILLION)
8.3.1.2 By functionality
8.3.1.2.1 Spot reduction
8.3.1.2.2 Skin treatment/Wound healing
8.3.1.2.3 Skin moisturization & hydration
8.3.1.2.4 Anti-irritation/Anti-inflammatory
8.3.1.2.5 Collagen stimulation & anti-aging
8.3.1.2.6 Other personal care functionalities
TABLE 33 PERSONAL CARE: BETA-GLUCAN MARKET, BY FUNCTIONALITY, 2019–2023 (USD MILLION)
TABLE 34 PERSONAL CARE: BETA-GLUCAN MARKET, BY FUNCTIONALITY, 2024–2029 (USD MILLION)
8.4 COSMETICS
8.4.1 BETA-GLUCAN TO IMPROVE SPREADABILITY OF FORMULATIONS AND ENHANCE THEIR ADHERENCE TO SKIN
TABLE 35 COSMETICS: BETA-GLUCAN MARKET, BY REGION, 2019–2023 (USD MILLION)
TABLE 36 COSMETICS: BETA-GLUCAN MARKET, BY REGION, 2024–2029 (USD MILLION)
8.4.1.1 By form
8.4.1.1.1 Creams
8.4.1.1.2 Lotions
8.4.1.1.3 Other cosmetics forms
TABLE 37 COSMETICS: BETA-GLUCAN MARKET, BY FORM, 2019–2023 (USD MILLION)
TABLE 38 COSMETICS: BETA-GLUCAN MARKET, BY FORM, 2024–2029 (USD MILLION)
8.4.1.2 By functionality
8.4.1.2.1 UV protection
8.4.1.2.2 Barrier enhancement
8.4.1.2.3 Skin moisturization & hydration
8.4.1.2.4 Collagen stimulation & anti-aging
8.4.1.2.5 Other cosmetics functionalities
TABLE 39 COSMETICS: BETA-GLUCAN MARKET, BY FUNCTIONALITY, 2019–2023 (USD MILLION)
TABLE 40 COSMETICS: BETA-GLUCAN MARKET, BY FUNCTIONALITY, 2024–2029 (USD MILLION)
8.5 PHARMACEUTICALS
8.5.1 GOVERNMENT INVESTMENT IN BENEFITS OF BETA-GLUCAN IN PHARMACEUTICAL APPLICATIONS TO SPUR MARKET
TABLE 41 PHARMACEUTICALS: BETA-GLUCAN MARKET, BY REGION, 2019–2023 (USD MILLION)
TABLE 42 PHARMACEUTICALS: BETA-GLUCAN MARKET, BY REGION, 2024–2029 (USD MILLION)
8.6 DIETARY SUPPLEMENTS
8.6.1 NEED FOR IMMUNE SYSTEM SUPPORT, CHOLESTEROL REDUCTION, AND IMPROVED GUT HEALTH TO FUEL DEMAND FOR BETA-GLUCAN
TABLE 43 DIETARY SUPPLEMENTS: BETA-GLUCAN MARKET, BY REGION, 2019–2023 (USD MILLION)
TABLE 44 DIETARY SUPPLEMENTS: BETA-GLUCAN MARKET, BY REGION, 2024–2029 (USD MILLION)
8.7 ANIMAL FEED
8.7.1 BETA-GLUCAN TO IMPROVE GROWTH AND FEED EFFICIENCY IN LIVESTOCK AND HELP THEM RESIST INFECTIONS AND DISEASES
TABLE 45 ANIMAL FEED: BETA-GLUCAN MARKET, BY REGION, 2019–2023 (USD MILLION)
TABLE 46 ANIMAL FEED: BETA-GLUCAN MARKET, BY REGION, 2024–2029 (USD MILLION)
TABLE 47 ANIMAL FEED: BETA-GLUCAN MARKET, BY SUB-APPLICATION, 2019–2023 (USD MILLION)
TABLE 48 ANIMAL FEED: BETA-GLUCAN MARKET, BY SUB-APPLICATION, 2024–2029 (USD MILLION)
8.7.1.1 Pets
8.7.1.2 Livestock
9 BETA-GLUCAN MARKET, BY BRAND
9.1 INTRODUCTION
9.2 EPICOR
9.3 BETAVIA
9.4 M-GARD
9.5 AVENACARE
9.6 AB BIOTEK HUMAN NUTRITION AND HEALTH
9.7 YESTIMUN
9.8 BENICAROS
9.9 IMMUDYNE NUTRITIONAL PUREMUNE
9.10 WELLMUNE
9.11 OTHER BRANDS
9.11.1 OATWELL
9.11.2 PROMOAT
9.11.3 SANACEL
9.11.4 AVENACARE
9.11.5 NUTRIM
10 BETA-GLUCAN MARKET, BY CATEGORY
10.1 INTRODUCTION
FIGURE 48 BETA-GLUCAN MARKET, BY CATEGORY, 2024 VS. 2029 (USD MILLION)
TABLE 49 BETA-GLUCAN MARKET, BY CATEGORY, 2019–2023 (USD MILLION)
TABLE 50 BETA-GLUCAN MARKET, BY CATEGORY, 2024–2029 (USD MILLION)
10.2 SOLUBLE BETA-GLUCAN
10.2.1 SOLUBLE BETA-GLUCAN TO REDUCE CHOLESTEROL LEVELS AND IMPROVE IMMUNE FUNCTION
TABLE 51 SOLUBLE: BETA-GLUCAN MARKET, BY REGION, 2019–2023 (USD MILLION)
TABLE 52 SOLUBLE: BETA-GLUCAN MARKET, BY REGION, 2024–2029 (USD MILLION)
10.3 INSOLUBLE BETA-GLUCAN
10.3.1 INSOLUBLE BETA-GLUCAN TO MAINTAIN HEALTHY DIGESTIVE SYSTEM BY FACILITATING SMOOTH MOVEMENT OF FOOD THROUGH DIGESTIVE TRACT
TABLE 53 INSOLUBLE: BETA-GLUCAN MARKET, BY REGION, 2019–2023 (USD MILLION)
TABLE 54 INSOLUBLE: BETA-GLUCAN MARKET, BY REGION, 2024–2029 (USD MILLION)
11 BETA-GLUCAN MARKET, BY SOURCE
11.1 INTRODUCTION
FIGURE 49 BETA-GLUCAN MARKET, BY SOURCE, 2024 VS. 2029 (USD MILLION)
TABLE 55 BETA-GLUCAN MARKET, BY SOURCE, 2019–2023 (USD MILLION)
TABLE 56 BETA-GLUCAN MARKET, BY SOURCE, 2024–2029 (USD MILLION)
TABLE 57 BETA-GLUCAN MARKET, BY SOURCE, 2019–2023 (TONS)
TABLE 58 BETA-GLUCAN MARKET, BY SOURCE, 2024–2029 (TONS)
11.2 CEREALS & GRAINS
11.2.1 NEED FOR REDUCING CHOLESTEROL LEVELS, IMPROVING HEART HEALTH, AND BOOSTING IMMUNE SYSTEM TO DRIVE MARKET
TABLE 59 CEREALS & GRAINS: BETA-GLUCAN MARKET, BY REGION, 2019–2023 (USD MILLION)
TABLE 60 CEREALS & GRAINS: BETA-GLUCAN MARKET, BY REGION, 2024–2029 (USD MILLION)
TABLE 61 CEREALS & GRAINS: BETA-GLUCAN MARKET, BY REGION, 2019–2023 (TONS)
TABLE 62 CEREALS & GRAINS: BETA-GLUCAN MARKET, BY REGION, 2024–2029 (TONS)
11.3 MUSHROOMS
11.3.1 GLUCAN FROM MUSHROOMS TO OFFER IMMUNE HEALTH BENEFITS AND IMPROVE SKIN HEALTH AND ANTI-INFLAMMATORY EFFECTS
TABLE 63 MUSHROOMS: BETA-GLUCAN MARKET, BY REGION, 2019–2023 (USD MILLION)
TABLE 64 MUSHROOMS: BETA-GLUCAN MARKET, BY REGION, 2024–2029 (USD MILLION)
TABLE 65 MUSHROOMS: BETA-GLUCAN MARKET, BY REGION, 2019–2023 (TONS)
TABLE 66 MUSHROOMS: BETA-GLUCAN MARKET, BY REGION, 2024–2029 (TONS)
11.4 YEAST
11.4.1 RISING PREVALENCE OF CHRONIC DISEASES, GROWING AWARENESS ABOUT HEALTH BENEFITS OF BETA-GLUCAN, AND SUPPORT OF GOVERNMENTS FOR RESEARCH AND DEVELOPMENT TO FOSTER MARKET
TABLE 67 YEAST: BETA-GLUCAN MARKET, BY REGION, 2019–2023 (USD MILLION)
TABLE 68 YEAST: BETA-GLUCAN MARKET, BY REGION, 2024–2029 (USD MILLION)
TABLE 69 YEAST: BETA-GLUCAN MARKET, BY REGION, 2019–2023 (TONS)
TABLE 70 YEAST: BETA-GLUCAN MARKET, BY REGION, 2024–2029 (TONS)
11.5 SEAWEED
11.5.1 SEAWEED-BASED BETA-GLUCAN TO BE USED IN COSMETIC AND PERSONAL CARE PRODUCTS FOR ITS MOISTURIZING, ANTI-INFLAMMATORY, AND ANTIOXIDANT PROPERTIES
TABLE 71 SEAWEED: BETA-GLUCAN MARKET, BY REGION, 2019–2023 (USD MILLION)
TABLE 72 SEAWEED: BETA-GLUCAN MARKET, BY REGION, 2024–2029 (USD MILLION)
TABLE 73 SEAWEED: BETA-GLUCAN MARKET, 2019–2023 (TONS)
TABLE 74 SEAWEED: BETA-GLUCAN MARKET, 2024–2029 (TONS)
12 BETA-GLUCAN MARKET, BY TYPE
12.1 INTRODUCTION
FIGURE 50 BETA-GLUCAN MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
TABLE 75 BETA-GLUCAN MARKET, BY TYPE, 2019–2023 (USD MILLION)
TABLE 76 BETA-GLUCAN MARKET, BY TYPE, 2024–2029 (USD MILLION)
12.2 1,3 BETA-GLUCAN
12.2.1 1,3 BETA-GLUCAN TO ENHANCE IMMUNE FUNCTION BY ACTIVATING VARIOUS IMMUNE CELLS AND IMPROVE SKIN HEALTH
TABLE 77 1,3 BETA-GLUCAN: BETA-GLUCAN MARKET, BY REGION, 2019–2023 (USD MILLION)
TABLE 78 1,3 BETA-GLUCAN: BETA-GLUCAN MARKET, BY REGION, 2024–2029 (USD MILLION)
12.3 1,4 BETA-GLUCAN
12.3.1 OAT AND BARLEY-DERIVED 1,4 BETA-GLUCAN TO LOWER CHOLESTEROL AND ENHANCE CARDIOVASCULAR HEALTH
TABLE 79 1,4 BETA-GLUCAN: BETA-GLUCAN MARKET, BY REGION, 2019–2023 (USD MILLION)
TABLE 80 1,4 BETA-GLUCAN: BETA-GLUCAN MARKET, BY REGION, 2024–2029 (USD MILLION)
12.4 1,6 BETA-GLUCAN
12.4.1 DEMAND FOR 1,6 BETA-GLUCAN TO RISE DUE TO ITS IMMUNE-BOOSTING AND SKIN HEALTH BENEFITS
TABLE 81 1,6 BETA-GLUCAN: BETA-GLUCAN MARKET, BY REGION, 2019–2023 (USD MILLION)
TABLE 82 1,6 BETA-GLUCAN: BETA-GLUCAN MARKET, BY REGION, 2024–2029 (USD MILLION)
13 BETA-GLUCAN MARKET, BY REGION
13.1 INTRODUCTION
FIGURE 51 ASIA PACIFIC COUNTRIES TO WITNESS SIGNIFICANT GROWTH IN BETA-GLUCAN MARKET, 2024–2029
TABLE 83 BETA-GLUCAN MARKET, BY REGION, 2019–2023 (USD MILLION)
TABLE 84 BETA-GLUCAN MARKET, BY REGION, 2024–2029 (USD MILLION)
TABLE 85 BETA-GLUCAN MARKET, BY REGION, 2019–2023 (TONS)
TABLE 86 BETA-GLUCAN MARKET, BY REGION, 2024–2029 (TONS)
13.2 NORTH AMERICA
FIGURE 52 NORTH AMERICA: BETA-GLUCAN MARKET SNAPSHOT
13.2.1 NORTH AMERICA: RECESSION IMPACT ANALYSIS
FIGURE 53 NORTH AMERICA: COUNTRY-LEVEL DATA OF INFLATION, 2017–2022
FIGURE 54 NORTH AMERICAN BETA-GLUCAN MARKET: RECESSION IMPACT ANALYSIS
TABLE 87 NORTH AMERICA: BETA-GLUCAN MARKET, BY COUNTRY, 2019–2023 (USD MILLION)
TABLE 88 NORTH AMERICA: BETA-GLUCAN MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
TABLE 89 NORTH AMERICA: BETA-GLUCAN MARKET, BY SOURCE, 2019–2023 (USD MILLION)
TABLE 90 NORTH AMERICA: BETA-GLUCAN MARKET, BY SOURCE, 2024–2029 (USD MILLION)
TABLE 91 NORTH AMERICA: BETA-GLUCAN MARKET, BY SOURCE, 2019–2023 (TONS)
TABLE 92 NORTH AMERICA: BETA-GLUCAN MARKET, BY SOURCE, 2024–2029 (TONS)
TABLE 93 NORTH AMERICA: BETA-GLUCAN MARKET, BY CATEGORY, 2019–2023 (USD MILLION)
TABLE 94 NORTH AMERICA: BETA-GLUCAN MARKET, BY CATEGORY, 2024–2029 (USD MILLION)
TABLE 95 NORTH AMERICA: BETA-GLUCAN MARKET, BY TYPE, 2019–2023 (USD MILLION)
TABLE 96 NORTH AMERICA: BETA-GLUCAN MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 97 NORTH AMERICA: BETA-GLUCAN MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 98 NORTH AMERICA: BETA-GLUCAN MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 99 NORTH AMERICA: BETA-GLUCAN PERSONAL CARE MARKET, BY FORM, 2019–2023 (USD MILLION)
TABLE 100 NORTH AMERICA: BETA-GLUCAN PERSONAL CARE MARKET, BY FORM, 2024–2029 (USD MILLION)
TABLE 101 NORTH AMERICA: BETA-GLUCAN PERSONAL CARE MARKET, BY FUNCTIONALITY, 2019–2023 (USD MILLION)
TABLE 102 NORTH AMERICA: BETA-GLUCAN PERSONAL CARE MARKET, BY FUNCTIONALITY, 2024–2029 (USD MILLION)
TABLE 103 NORTH AMERICA: BETA-GLUCAN COSMETICS MARKET, BY FORM, 2019–2023 (USD MILLION)
TABLE 104 NORTH AMERICA: BETA-GLUCAN COSMETICS MARKET, BY FORM, 2024–2029 (USD MILLION)
TABLE 105 NORTH AMERICA: BETA-GLUCAN COSMETICS MARKET, BY FUNCTIONALITY, 2019–2023 (USD MILLION)
TABLE 106 NORTH AMERICA: BETA-GLUCAN COSMETICS MARKET, BY FUNCTIONALITY, 2024–2029 (USD MILLION)
TABLE 107 NORTH AMERICA: BETA-GLUCAN ANIMAL FEED MARKET, BY SUB-APPLICATION, 2019–2023 (USD MILLION)
TABLE 108 NORTH AMERICA: BETA-GLUCAN ANIMAL FEED MARKET, BY SUB-APPLICATION, 2024–2029 (USD MILLION)
13.2.2 US
13.2.2.1 Increasing number of product launches by food manufacturers to fuel demand for beta-glucan
TABLE 109 US: BETA-GLUCAN MARKET, BY CATEGORY, 2019–2023 (USD MILLION)
TABLE 110 US: BETA-GLUCAN MARKET, BY CATEGORY, 2024–2029 (USD MILLION)
TABLE 111 US: BETA-GLUCAN MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 112 US: BETA-GLUCAN MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
13.2.3 CANADA
13.2.3.1 Government approvals and rising efforts from market players to accelerate market growth
TABLE 113 CANADA: BETA-GLUCAN MARKET, BY CATEGORY, 2019–2023 (USD MILLION)
TABLE 114 CANADA: BETA-GLUCAN MARKET, BY CATEGORY, 2024–2029 (USD MILLION)
TABLE 115 CANADA: BETA-GLUCAN MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 116 CANADA: BETA-GLUCAN MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
13.2.4 MEXICO
13.2.4.1 Rise in chronic lifestyle diseases, demand for health-benefiting products, and government initiatives to promote healthy lifestyles to drive market
TABLE 117 MEXICO: BETA-GLUCAN MARKET, BY CATEGORY, 2019–2023 (USD MILLION)
TABLE 118 MEXICO: BETA-GLUCAN MARKET, BY CATEGORY, 2024–2029 (USD MILLION)
TABLE 119 MEXICO: BETA-GLUCAN MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 120 MEXICO: BETA-GLUCAN MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
13.3 EUROPE
13.3.1 EUROPE: RECESSION IMPACT ANALYSIS
FIGURE 55 EUROPE: COUNTRY-LEVEL DATA FOR INFLATION, 2017–2022
FIGURE 56 EUROPEAN BETA-GLUCAN MARKET: RECESSION IMPACT ANALYSIS
TABLE 121 EUROPE: BETA-GLUCAN MARKET, BY COUNTRY, 2019–2023 (USD MILLION)
TABLE 122 EUROPE: BETA-GLUCAN MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
TABLE 123 EUROPE: BETA-GLUCAN MARKET, BY SOURCE, 2019–2023 (USD MILLION)
TABLE 124 EUROPE: BETA-GLUCAN MARKET, BY SOURCE, 2024–2029 (USD MILLION)
TABLE 125 EUROPE: BETA-GLUCAN MARKET, BY SOURCE, 2019–2023 (TONS)
TABLE 126 EUROPE: BETA-GLUCAN MARKET, BY SOURCE, 2024–2029 (TONS)
TABLE 127 EUROPE: BETA-GLUCAN MARKET, BY CATEGORY, 2019–2023 (USD MILLION)
TABLE 128 EUROPE: BETA-GLUCAN MARKET, BY CATEGORY, 2024–2029 (USD MILLION)
TABLE 129 EUROPE: BETA-GLUCAN MARKET, BY TYPE, 2019–2023 (USD MILLION)
TABLE 130 EUROPE: BETA-GLUCAN MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 131 EUROPE: BETA-GLUCAN MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 132 EUROPE: BETA-GLUCAN MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 133 EUROPE: BETA-GLUCAN PERSONAL CARE MARKET, BY FORM, 2019–2023 (USD MILLION)
TABLE 134 EUROPE: BETA-GLUCAN PERSONAL CARE MARKET, BY FORM, 2024–2029 (USD MILLION)
TABLE 135 EUROPE: BETA-GLUCAN PERSONAL CARE MARKET, BY FUNCTIONALITY, 2019–2023 (USD MILLION)
TABLE 136 EUROPE: BETA-GLUCAN PERSONAL CARE MARKET, BY FUNCTIONALITY, 2024–2029 (USD MILLION)
TABLE 137 EUROPE: BETA-GLUCAN COSMETICS MARKET, BY FORM, 2019–2023 (USD MILLION)
TABLE 138 EUROPE: BETA-GLUCAN COSMETICS MARKET, BY FORM, 2024–2029 (USD MILLION)
TABLE 139 EUROPE: BETA-GLUCAN COSMETICS MARKET, BY FUNCTIONALITY, 2019–2023 (USD MILLION)
TABLE 140 EUROPE: BETA-GLUCAN COSMETICS MARKET, BY FUNCTIONALITY, 2024–2029 (USD MILLION)
TABLE 141 EUROPE: BETA-GLUCAN ANIMAL FEED MARKET, BY SUB-APPLICATION, 2019–2023 (USD MILLION)
TABLE 142 EUROPE: BETA-GLUCAN ANIMAL FEED MARKET, BY SUB-APPLICATION, 2024–2029 (USD MILLION)
13.3.2 GERMANY
13.3.2.1 Inclination toward natural and organic foods and rising prevalence of health-related problems to propel market
TABLE 143 GERMANY: BETA-GLUCAN MARKET, BY CATEGORY, 2019–2023 (USD MILLION)
TABLE 144 GERMANY: BETA-GLUCAN MARKET, BY CATEGORY, 2024–2029 (USD MILLION)
TABLE 145 GERMANY: BETA-GLUCAN MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 146 GERMANY: BETA-GLUCAN MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
13.3.3 FRANCE
13.3.3.1 Rising incidence of lifestyle diseases, growing demand for functional foods, and favorable government policies to drive market
TABLE 147 FRANCE: BETA-GLUCAN MARKET, BY CATEGORY, 2019–2023 (USD MILLION)
TABLE 148 FRANCE: BETA-GLUCAN MARKET, BY CATEGORY, 2024–2029 (USD MILLION)
TABLE 149 FRANCE: BETA-GLUCAN MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 150 FRANCE: BETA-GLUCAN MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
13.3.4 UK
13.3.4.1 Rising demand for healthier and more sustainable products and government’s focus on awareness programs to promote healthy diet to drive market
TABLE 151 UK: BETA-GLUCAN MARKET, BY CATEGORY, 2019–2023 (USD MILLION)
TABLE 152 UK: BETA-GLUCAN MARKET, BY CATEGORY, 2024–2029 (USD MILLION)
TABLE 153 UK: BETA-GLUCAN MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 154 UK: BETA-GLUCAN MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
13.3.5 ITALY
13.3.5.1 Rising demand for health-enriching ingredients to prevent risk of chronic diseases to foster market growth
TABLE 155 ITALY: BETA-GLUCAN MARKET, BY CATEGORY, 2019–2023 (USD MILLION)
TABLE 156 ITALY: BETA-GLUCAN MARKET, BY CATEGORY, 2024–2029 (USD MILLION)
TABLE 157 ITALY: BETA-GLUCAN MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 158 ITALY: BETA-GLUCAN MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
13.3.6 SPAIN
13.3.6.1 Rising export opportunities and need to optimize animal health to boost demand for beta-glucan
TABLE 159 SPAIN: BETA-GLUCAN MARKET, BY CATEGORY, 2019–2023 (USD MILLION)
TABLE 160 SPAIN: BETA-GLUCAN MARKET, BY CATEGORY, 2024–2029 (USD MILLION)
TABLE 161 SPAIN: BETA-GLUCAN MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 162 SPAIN: BETA-GLUCAN MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
13.3.7 REST OF EUROPE
TABLE 163 REST OF EUROPE: BETA-GLUCAN MARKET, BY CATEGORY, 2019–2023 (USD MILLION)
TABLE 164 REST OF EUROPE: BETA-GLUCAN MARKET, BY CATEGORY, 2024–2029 (USD MILLION)
TABLE 165 REST OF EUROPE: BETA-GLUCAN MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 166 REST OF EUROPE: BETA-GLUCAN MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
13.4 ASIA PACIFIC
FIGURE 57 ASIA PACIFIC: BETA-GLUCAN MARKET SNAPSHOT
13.4.1 ASIA PACIFIC: RECESSION IMPACT ANALYSIS
FIGURE 58 ASIA PACIFIC: KEY COUNTRY-WISE INFLATION RATES, 2017–2022
FIGURE 59 ASIA PACIFIC: RECESSION IMPACT ANALYSIS, 2023
TABLE 167 ASIA PACIFIC: BETA-GLUCAN MARKET, BY COUNTRY, 2019–2023 (USD MILLION)
TABLE 168 ASIA PACIFIC: BETA-GLUCAN MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
TABLE 169 ASIA PACIFIC: BETA-GLUCAN MARKET, BY SOURCE, 2019–2023 (USD MILLION)
TABLE 170 ASIA PACIFIC: BETA-GLUCAN MARKET, BY SOURCE, 2024–2029 (USD MILLION)
TABLE 171 ASIA PACIFIC: BETA-GLUCAN MARKET, BY SOURCE, 2019–2023 (TONS)
TABLE 172 ASIA PACIFIC: BETA-GLUCAN MARKET, BY SOURCE, 2024–2029 (TONS)
TABLE 173 ASIA PACIFIC: BETA-GLUCAN MARKET, BY CATEGORY, 2019–2023 (USD MILLION)
TABLE 174 ASIA PACIFIC: BETA-GLUCAN MARKET, BY CATEGORY, 2024–2029 (USD MILLION)
TABLE 175 ASIA PACIFIC: BETA-GLUCAN MARKET, BY TYPE, 2019–2023 (USD MILLION)
TABLE 176 ASIA PACIFIC: BETA-GLUCAN MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 177 ASIA PACIFIC: BETA-GLUCAN MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 178 ASIA PACIFIC: BETA-GLUCAN MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 179 ASIA PACIFIC: BETA-GLUCAN PERSONAL CARE MARKET, BY FORM, 2019–2023 (USD MILLION)
TABLE 180 ASIA PACIFIC: BETA-GLUCAN PERSONAL CARE MARKET, BY FORM, 2024–2029 (USD MILLION)
TABLE 181 ASIA PACIFIC: BETA-GLUCAN PERSONAL CARE MARKET, BY FUNCTIONALITY, 2019–2023 (USD MILLION)
TABLE 182 ASIA PACIFIC: BETA-GLUCAN PERSONAL CARE MARKET, BY FUNCTIONALITY, 2024–2029 (USD MILLION)
TABLE 183 ASIA PACIFIC: BETA-GLUCAN COSMETICS MARKET, BY FORM, 2019–2023 (USD MILLION)
TABLE 184 ASIA PACIFIC: BETA-GLUCAN COSMETICS MARKET, BY FORM, 2024–2029 (USD MILLION)
TABLE 185 ASIA PACIFIC: BETA-GLUCAN COSMETICS MARKET, BY FUNCTIONALITY, 2019–2023 (USD MILLION)
TABLE 186 ASIA PACIFIC: BETA-GLUCAN COSMETICS MARKET, BY FUNCTIONALITY, 2024–2029 (USD MILLION)
TABLE 187 ASIA PACIFIC: BETA-GLUCAN ANIMAL FEED MARKET, BY SUB-APPLICATION, 2019–2023 (USD MILLION)
TABLE 188 ASIA PACIFIC: BETA-GLUCAN ANIMAL FEED MARKET, BY SUB-APPLICATION, 2024–2029 (USD MILLION)
13.4.2 CHINA
13.4.2.1 Higher demand for high-quality processed foods and presence of major vendors to foster market growth
TABLE 189 CHINA: BETA-GLUCAN MARKET, BY CATEGORY, 2019–2023 (USD MILLION)
TABLE 190 CHINA: BETA-GLUCAN MARKET, BY CATEGORY, 2024–2029 (USD MILLION)
TABLE 191 CHINA: BETA-GLUCAN MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 192 CHINA: BETA-GLUCAN MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
13.4.3 JAPAN
13.4.3.1 Rise in healthcare costs and higher life expectancy due to preventive healthcare measures to drive market
TABLE 193 JAPAN: BETA-GLUCAN MARKET, BY CATEGORY, 2019–2023 (USD MILLION)
TABLE 194 JAPAN: BETA-GLUCAN MARKET, BY CATEGORY, 2024–2029 (USD MILLION)
TABLE 195 JAPAN: BETA-GLUCAN MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 196 JAPAN: BETA-GLUCAN MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
13.4.4 INDIA
13.4.4.1 Promotion of innovation and product development in food industry to fuel demand for beta-glucan
TABLE 197 INDIA: BETA-GLUCAN MARKET, BY CATEGORY, 2019–2023 (USD MILLION)
TABLE 198 INDIA: BETA-GLUCAN MARKET, BY CATEGORY, 2024–2029 (USD MILLION)
TABLE 199 INDIA: BETA-GLUCAN MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 200 INDIA: BETA-GLUCAN MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
13.4.5 AUSTRALIA & NEW ZEALAND
13.4.5.1 Need to promote animal growth, boost immunity, and improve overall productivity to propel market
TABLE 201 AUSTRALIA & NEW ZEALAND: BETA-GLUCAN MARKET, BY CATEGORY, 2019–2023 (USD MILLION)
TABLE 202 AUSTRALIA & NEW ZEALAND: BETA-GLUCAN MARKET, BY CATEGORY, 2024–2029 (USD MILLION)
TABLE 203 AUSTRALIA & NEW ZEALAND: BETA-GLUCAN MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 204 AUSTRALIA & NEW ZEALAND: BETA-GLUCAN MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
13.4.6 REST OF ASIA PACIFIC
TABLE 205 REST OF ASIA PACIFIC: BETA-GLUCAN MARKET, BY CATEGORY, 2019–2023 (USD MILLION)
TABLE 206 REST OF ASIA PACIFIC: BETA-GLUCAN MARKET, BY CATEGORY, 2024–2029 (USD MILLION)
TABLE 207 REST OF ASIA PACIFIC: BETA-GLUCAN MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 208 REST OF ASIA PACIFIC: BETA-GLUCAN MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
13.5 SOUTH AMERICA
13.5.1 SOUTH AMERICA: RECESSION IMPACT ANALYSIS
FIGURE 60 SOUTH AMERICA: COUNTRY-LEVEL DATA FOR INFLATION, 2017–2022
FIGURE 61 SOUTH AMERICA BETA-GLUCAN MARKET: RECESSION IMPACT ANALYSIS
TABLE 209 SOUTH AMERICA: BETA-GLUCAN MARKET, BY COUNTRY, 2019–2023 (USD MILLION)
TABLE 210 SOUTH AMERICA: BETA-GLUCAN MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
TABLE 211 SOUTH AMERICA: BETA-GLUCAN MARKET, BY SOURCE, 2019–2023 (USD MILLION)
TABLE 212 SOUTH AMERICA: BETA-GLUCAN MARKET, BY SOURCE, 2024–2029 (USD MILLION)
TABLE 213 SOUTH AMERICA: BETA-GLUCAN MARKET, BY SOURCE, 2019–2023 (TONS)
TABLE 214 SOUTH AMERICA: BETA-GLUCAN MARKET, BY SOURCE, 2024–2029 (TONS)
TABLE 215 SOUTH AMERICA: BETA-GLUCAN MARKET, BY CATEGORY, 2019–2023 (USD MILLION)
TABLE 216 SOUTH AMERICA: BETA-GLUCAN MARKET, BY CATEGORY, 2024–2029 (USD MILLION)
TABLE 217 SOUTH AMERICA: BETA-GLUCAN MARKET, BY TYPE, 2019–2023 (USD MILLION)
TABLE 218 SOUTH AMERICA: BETA-GLUCAN MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 219 SOUTH AMERICA: BETA-GLUCAN MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 220 SOUTH AMERICA: BETA-GLUCAN MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 221 SOUTH AMERICA: BETA-GLUCAN PERSONAL CARE MARKET, BY FORM, 2019–2023 (USD MILLION)
TABLE 222 SOUTH AMERICA: BETA-GLUCAN PERSONAL CARE MARKET, BY FORM, 2024–2029 (USD MILLION)
TABLE 223 SOUTH AMERICA: BETA-GLUCAN PERSONAL CARE MARKET, BY FUNCTIONALITY, 2019–2023 (USD MILLION)
TABLE 224 SOUTH AMERICA: BETA-GLUCAN PERSONAL CARE MARKET, BY FUNCTIONALITY, 2024–2029 (USD MILLION)
TABLE 225 SOUTH AMERICA: BETA-GLUCAN COSMETICS MARKET, BY FORM, 2019–2023 (USD MILLION)
TABLE 226 SOUTH AMERICA: BETA-GLUCAN COSMETICS MARKET, BY FORM, 2024–2029 (USD MILLION)
TABLE 227 SOUTH AMERICA: BETA-GLUCAN COSMETICS MARKET, BY FUNCTIONALITY, 2019–2023 (USD MILLION)
TABLE 228 SOUTH AMERICA: BETA-GLUCAN COSMETICS MARKET, BY FUNCTIONALITY, 2024–2029 (USD MILLION)
TABLE 229 SOUTH AMERICA: BETA-GLUCAN ANIMAL FEED MARKET, BY SUB-APPLICATION, 2019–2023 (USD MILLION)
TABLE 230 SOUTH AMERICA: BETA-GLUCAN ANIMAL FEED MARKET, BY SUB-APPLICATION, 2024–2029 (USD MILLION)
13.5.2 BRAZIL
13.5.2.1 Rising geriatric population, surge in obesity levels, urbanization, and health consciousness to spur market growth
TABLE 231 BRAZIL: BETA-GLUCAN MARKET, BY CATEGORY, 2019–2023 (USD MILLION)
TABLE 232 BRAZIL: BETA-GLUCAN MARKET, BY CATEGORY, 2024–2029 (USD MILLION)
TABLE 233 BRAZIL: BETA-GLUCAN MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 234 BRAZIL: BETA-GLUCAN MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
13.5.3 ARGENTINA
13.5.3.1 Need for reducing cholesterol levels and promoting digestion to fuel demand for oats-derived beta-glucan
TABLE 235 ARGENTINA: BETA-GLUCAN MARKET, BY CATEGORY, 2019–2023 (USD MILLION)
TABLE 236 ARGENTINA: BETA-GLUCAN MARKET, BY CATEGORY, 2024–2029 (USD MILLION)
TABLE 237 ARGENTINA: BETA-GLUCAN MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 238 ARGENTINA: BETA-GLUCAN MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
13.5.4 REST OF SOUTH AMERICA
TABLE 239 REST OF SOUTH AMERICA: BETA-GLUCAN MARKET, BY CATEGORY, 2019–2023 (USD MILLION)
TABLE 240 REST OF SOUTH AMERICA: BETA-GLUCAN MARKET, BY CATEGORY, 2024–2029 (USD MILLION)
TABLE 241 REST OF SOUTH AMERICA: BETA-GLUCAN MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 242 REST OF SOUTH AMERICA: BETA-GLUCAN MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
13.6 REST OF THE WORLD (ROW)
13.6.1 ROW: RECESSION IMPACT ANALYSIS
FIGURE 62 ROW: KEY COUNTRY-WISE INFLATION RATES, 2017–2022
FIGURE 63 ROW: RECESSION IMPACT ANALYSIS, 2023
TABLE 243 ROW: BETA-GLUCAN MARKET, BY COUNTRY, 2019–2023 (USD MILLION)
TABLE 244 ROW: BETA-GLUCAN MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
TABLE 245 ROW: BETA-GLUCAN MARKET, BY SOURCE, 2019–2023 (USD MILLION)
TABLE 246 ROW: BETA-GLUCAN MARKET, BY SOURCE, 2024–2029 (USD MILLION)
TABLE 247 ROW: BETA-GLUCAN MARKET, BY SOURCE, 2019–2023 (TONS)
TABLE 248 ROW: BETA-GLUCAN MARKET, BY SOURCE, 2024–2029 (TONS)
TABLE 249 ROW: BETA-GLUCAN MARKET, BY CATEGORY, 2019–2023 (USD MILLION)
TABLE 250 ROW: BETA-GLUCAN MARKET, BY CATEGORY, 2024–2029 (USD MILLION)
TABLE 251 ROW: BETA-GLUCAN MARKET, BY TYPE, 2019–2023 (USD MILLION)
TABLE 252 ROW: BETA-GLUCAN MARKET, BY TYPE, 2024–2029 (USD MILLION)
TABLE 253 ROW: BETA-GLUCAN MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 254 ROW: BETA-GLUCAN MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
TABLE 255 ROW: BETA-GLUCAN PERSONAL CARE MARKET, BY FORM, 2019–2023 (USD MILLION)
TABLE 256 ROW: BETA-GLUCAN PERSONAL CARE MARKET, BY FORM, 2024–2029 (USD MILLION)
TABLE 257 ROW: BETA-GLUCAN PERSONAL CARE MARKET, BY FUNCTIONALITY, 2019–2023 (USD MILLION)
TABLE 258 ROW: BETA-GLUCAN PERSONAL CARE MARKET, BY FUNCTIONALITY, 2024–2029 (USD MILLION)
TABLE 259 ROW: BETA-GLUCAN COSMETICS MARKET, BY FORM, 2019–2023 (USD MILLION)
TABLE 260 ROW: BETA-GLUCAN COSMETICS MARKET, BY FORM, 2024–2029 (USD MILLION)
TABLE 261 ROW: BETA-GLUCAN COSMETICS MARKET, BY FUNCTIONALITY, 2019–2023 (USD MILLION)
TABLE 262 ROW: BETA-GLUCAN COSMETICS MARKET, BY FUNCTIONALITY, 2024–2029 (USD MILLION)
TABLE 263 ROW: BETA-GLUCAN ANIMAL FEED MARKET, BY SUB-APPLICATION, 2019–2023 (USD MILLION)
TABLE 264 ROW: BETA-GLUCAN ANIMAL FEED MARKET, BY SUB-APPLICATION, 2024–2029 (USD MILLION)
13.6.2 MIDDLE EAST
13.6.2.1 Expanding middle-class population and industrial growth and increased health and wellness initiatives in Middle East to drive market
TABLE 265 MIDDLE EAST: BETA-GLUCAN MARKET, BY CATEGORY, 2019–2023 (USD MILLION)
TABLE 266 MIDDLE EAST: BETA-GLUCAN MARKET, BY CATEGORY, 2024–2029 (USD MILLION)
TABLE 267 MIDDLE EAST: BETA-GLUCAN MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 268 MIDDLE EAST: BETA-GLUCAN MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
13.6.3 AFRICA
13.6.3.1 Growing demand for natural and functional ingredients to boost demand for beta-glucan ingredients
TABLE 269 AFRICA: BETA-GLUCAN MARKET, BY CATEGORY, 2019–2023 (USD MILLION)
TABLE 270 AFRICA: BETA-GLUCAN MARKET, BY CATEGORY, 2024–2029 (USD MILLION)
TABLE 271 AFRICA: BETA-GLUCAN MARKET, BY APPLICATION, 2019–2023 (USD MILLION)
TABLE 272 AFRICA: BETA-GLUCAN MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
14 COMPETITIVE LANDSCAPE
14.1 OVERVIEW
14.2 REVENUE ANALYSIS
FIGURE 64 SEGMENTAL REVENUE ANALYSIS OF KEY PLAYERS, 2019–2023 (USD BILLION)
14.3 MARKET SHARE ANALYSIS
TABLE 273 BETA-GLUCAN MARKET: MARKET SHARE ANALYSIS, 2023
14.4 KEY PLAYER STRATEGIES/RIGHT TO WIN
TABLE 274 OVERVIEW OF STRATEGIES ADOPTED BY KEY BETA-GLUCAN PLAYERS
14.5 COMPANY VALUATION AND FINANCIAL METRICS
FIGURE 65 COMPANY VALUATION
FIGURE 66 EV/EBITDA OF FEW MAJOR PLAYERS
14.6 BRAND/PRODUCT COMPARISON ANALYSIS
FIGURE 67 BETA-GLUCAN MARKET: BRAND/PRODUCT COMPARISON ANALYSIS
14.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
14.7.1 STARS
14.7.2 EMERGING LEADERS
14.7.3 PERVASIVE PLAYERS
14.7.4 PARTICIPANTS
FIGURE 68 BETA-GLUCAN MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2023
14.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
14.7.5.1 Company footprint
FIGURE 69 OVERALL COMPANY FOOTPRINT
14.7.5.2 Regional footprint
TABLE 275 REGIONAL FOOTPRINT
14.7.5.3 Source footprint
TABLE 276 SOURCE FOOTPRINT
14.7.5.4 Application footprint
TABLE 277 APPLICATION FOOTPRINT
14.7.5.5 Type footprint
TABLE 278 TYPE FOOTPRINT
14.8 COMPANY EVALUATION MATRIX: START-UPS/SMES, 2023
14.8.1 PROGRESSIVE COMPANIES
14.8.2 RESPONSIVE COMPANIES
14.8.3 DYNAMIC COMPANIES
14.8.4 STARTING BLOCKS
FIGURE 70 BETA-GLUCAN MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2023
14.8.5 COMPETITIVE BENCHMARKING, START-UPS/SMES, 2023
14.8.5.1 Detailed list of key start-ups/SMEs
TABLE 279 BETA-GLUCAN MARKET: LIST OF KEY START-UPS/SMES
14.8.5.2 Competitive benchmarking of key start-ups/SMEs
TABLE 280 BETA-GLUCAN MARKET: COMPETITIVE BENCHMARKING OF START-UPS/SMES
14.9 COMPETITIVE SCENARIO AND TRENDS
14.9.1 DEALS
TABLE 281 BETA-GLUCAN MARKET: DEALS, 2020–2022
14.9.2 EXPANSIONS
TABLE 282 BETA-GLUCAN MARKET: EXPANSIONS, 2019–2022
15 COMPANY PROFILES
(Business Overview, Products/Solutions Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
15.1 KEY PLAYERS
15.1.1 TATE & LYLE PLC
TABLE 283 TATE & LYLE PLC: BUSINESS OVERVIEW
FIGURE 71 TATE & LYLE PLC: COMPANY SNAPSHOT
TABLE 284 TATE & LYLE PLC: INGREDIENTS OFFERED
TABLE 285 TATE & LYLE PLC: DEALS
TABLE 286 TATE & LYLE PLC: EXPANSIONS
TABLE 287 TATE & LYLE PLC: OTHER DEVELOPMENTS
15.1.2 KERRY GROUP PLC
TABLE 288 KERRY GROUP PLC: BUSINESS OVERVIEW
FIGURE 72 KERRY GROUP PLC: COMPANY SNAPSHOT
TABLE 289 KERRY GROUP PLC: INGREDIENTS OFFERED
15.1.3 DSM-FIRMENICH
TABLE 290 DSM-FIRMENICH: BUSINESS OVERVIEW
FIGURE 73 DSM-FIRMENICH: COMPANY SNAPSHOT
TABLE 291 DSM-FIRMENICH: INGREDIENTS OFFERED
TABLE 292 DSM-FIRMENICH: EXPANSIONS
15.1.4 ANGEL YEAST CO., LTD.
TABLE 293 ANGEL YEAST CO., LTD.: BUSINESS OVERVIEW
FIGURE 74 ANGEL YEAST CO., LTD: COMPANY SNAPSHOT
TABLE 294 ANGEL YEAST CO., LTD.: INGREDIENTS OFFERED
TABLE 295 ANGEL YEAST CO., LTD.: PRODUCTS OFFERED
TABLE 296 ANGEL YEAST CO., LTD.: EXPANSIONS
15.1.5 MERCK
TABLE 297 MERCK: BUSINESS OVERVIEW
FIGURE 75 MERCK: COMPANY SNAPSHOT
TABLE 298 MERCK: INGREDIENTS OFFERED
TABLE 299 MERCK: EXPANSIONS
15.1.6 ASSOCIATED BRITISH FOODS PLC
TABLE 300 ASSOCIATED BRITISH FOODS PLC: BUSINESS OVERVIEW
FIGURE 76 ASSOCIATED BRITISH FOODS PLC: COMPANY SNAPSHOT
TABLE 301 ASSOCIATED BRITISH FOODS PLC: INGREDIENTS OFFERED
TABLE 302 ASSOCIATED BRITISH FOODS PLC: PRODUCTS OFFERED
15.1.7 CEAPRO INC.
TABLE 303 CEAPRO INC.: BUSINESS OVERVIEW
FIGURE 77 CEAPRO INC.: COMPANY SNAPSHOT
TABLE 304 CEAPRO INC.: INGREDIENTS OFFERED
TABLE 305 CEAPRO INC.: DEALS
TABLE 306 CEAPRO INC.: OTHER DEVELOPMENTS
15.1.8 LESAFFRE
TABLE 307 LESAFFRE: BUSINESS OVERVIEW
TABLE 308 LESAFFRE: INGREDIENTS OFFERED
TABLE 309 LESAFFRE: PRODUCTS OFFERED
TABLE 310 LESAFFRE: DEALS
15.1.9 KEMIN INDUSTRIES, INC.
TABLE 311 KEMIN INDUSTRIES, INC.: BUSINESS OVERVIEW
TABLE 312 KEMIN INDUSTRIES, INC.: INGREDIENTS OFFERED
TABLE 313 KEMIN INDUSTRIES, INC.: EXPANSIONS
TABLE 314 KEMIN INDUSTRIES, INC.: OTHER DEVELOPMENTS
15.1.10 FOODCHEM INTERNATIONAL CORPORATION
TABLE 315 FOODCHEM INTERNATIONAL CORPORATION: BUSINESS OVERVIEW
TABLE 316 FOODCHEM INTERNATIONAL CORPORATION: INGREDIENTS OFFERED
15.1.11 LALLEMAND
TABLE 317 LALLEMAND: BUSINESS OVERVIEW
TABLE 318 LALLEMAND: INGREDIENTS OFFERED
TABLE 319 LALLEMAND: PRODUCTS OFFERED
TABLE 320 LALLEMAND: DEALS
15.1.12 BIORIGIN
TABLE 321 BIORIGIN: BUSINESS OVERVIEW
TABLE 322 BIORIGIN: INGREDIENTS OFFERED
15.1.13 NUTRISCIENCE INNOVATIONS, LLC
TABLE 323 NUTRISCIENCE INNOVATIONS, LLC: BUSINESS OVERVIEW
TABLE 324 NUTRISCIENCE INNOVATIONS, LLC: INGREDIENTS OFFERED
15.1.14 LEIBER
TABLE 325 LEIBER: BUSINESS OVERVIEW
TABLE 326 LEIBER: INGREDIENTS OFFERED
TABLE 327 LEIBER: PRODUCTS OFFERED
15.1.15 GARUDA INTERNATIONAL INC.
TABLE 328 GARUDA INTERNATIONAL INC.: BUSINESS OVERVIEW
TABLE 329 GARUDA INTERNATIONAL INC.: INGREDIENTS OFFERED
15.2 OTHER PLAYERS
15.2.1 VW-INGREDIENTS
TABLE 330 VW-INGREDIENTS: BUSINESS OVERVIEW
TABLE 331 VW-INGREDIENTS: INGREDIENTS OFFERED
15.2.2 SUPER BETA GLUCAN
TABLE 332 SUPER BETA GLUCAN: BUSINESS OVERVIEW
TABLE 333 SUPER BETA GLUCAN: INGREDIENTS OFFERED
15.2.3 GLYCANOVA AS
TABLE 334 GLYCANOVA AS: BUSINESS OVERVIEW
TABLE 335 GLYCANOVA AS: INGREDIENTS OFFERED
TABLE 336 GLYCANOVA AS: PRODUCTS OFFERED
15.2.4 SPECIALTY BIOTECH CO., LTD.
TABLE 337 SPECIALTY BIOTECH CO., LTD.: BUSINESS OVERVIEW
TABLE 338 SPECIALTY BIOTECH CO., LTD.: INGREDIENTS OFFERED
15.2.5 ALGALНF ICELAND HF.
TABLE 339 ALGALНF ICELAND HF.: BUSINESS OVERVIEW
TABLE 340 ALGALНF ICELAND HF.: INGREDIENTS OFFERED
15.2.6 NATURAL BIOLOGICS
TABLE 341 NATURAL BIOLOGICS: BUSINESS OVERVIEW
15.2.7 ABAC R&D AG
TABLE 342 ABAC R&D AG: BUSINESS OVERVIEW
15.2.8 BENEO
TABLE 343 BENEO: BUSINESS OVERVIEW
15.2.9 L&P FOOD INGREDIENT CO., LTD
TABLE 344 L&P FOOD INGREDIENT CO., LTD: BUSINESS OVERVIEW
15.2.10 BETA BIO TECHNOLOGY SP. Z O. O.
TABLE 345 BETA BIO TECHNOLOGY SP. Z O. O. : BUSINESS OVERVIEW
15.3 PRODUCT-BASED COMPANIES
15.3.1 CARGILL, INCORPORATED
TABLE 346 CARGILL, INCORPORATED: BUSINESS OVERVIEW
15.3.2 INTERNATIONAL FLAVORS & FRAGRANCES, INC.
TABLE 347 INTERNATIONAL FLAVORS & FRAGRANCES, INC.: BUSINESS OVERVIEW
15.3.3 VIVESA HOLDING S.R.O
TABLE 348 VIVESA HOLDING S.R.O: BUSINESS OVERVIEW
15.3.4 ALERIS
TABLE 349 ALERIS: BUSINESS OVERVIEW
15.3.5 ICC
TABLE 350 ICC: BUSINESS OVERVIEW
15.3.6 PROSOL S.P.A.
TABLE 351 PROSOL S.P.A.: BUSINESS OVERVIEW
15.3.7 ABN APLICACIONES BIOLУGICAS A LA NUTRICIУN
TABLE 352 ABN APLICACIONES BIOLУGICAS A LA NUTRICIУN: BUSINESS OVERVIEW
15.3.8 EW NUTRITION
TABLE 353 EW NUTRITION: BUSINESS OVERVIEW
15.3.9 BIOCHEM ZUSATZSTOFFE HANDELS- UND PRODUKTIONSGESELLSCHAFT MBH
TABLE 354 BIOCHEM ZUSATZSTOFFE HANDELS- UND PRODUKTIONSGESELLSCHAFT MBH: BUSINESS OVERVIEW
15.3.10 MIBELLE BIOCHEMISTRY
TABLE 355 MIBELLE BIOCHEMISTRY: BUSINESS OVERVIEW
*Details on Business Overview, Products/Solutions Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
16 ADJACENT & RELATED MARKETS
16.1 INTRODUCTION
TABLE 356 ADJACENT MARKETS
16.2 STUDY LIMITATIONS
16.3 YEAST MARKET
16.3.1 MARKET DEFINITION
16.3.2 MARKET OVERVIEW
TABLE 357 YEAST MARKET, BY TYPE, 2019–2023 (USD MILLION)
TABLE 358 YEAST MARKET, BY TYPE, 2024–2029 (USD MILLION)
16.4 STARTER CULTURE MARKET
16.4.1 MARKET DEFINITION
16.4.2 MARKET OVERVIEW
TABLE 359 STARTER CULTURE MARKET, BY APPLICATION, 2017–2021 (USD MILLION)
TABLE 360 STARTER CULTURE MARKET, BY APPLICATION, 2022–2027 (USD MILLION)
17 APPENDIX
17.1 DISCUSSION GUIDE
17.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
17.3 CUSTOMIZATION OPTIONS
17.4 RELATED REPORTS
17.5 AUTHOR DETAILS
